Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
West Pharmaceutical Services, Inc. (WST)
USD357.52
-2.18 (-0.61%)
US NYSE S&P 500
Healthcare Medical - Instruments & Supplies
Address
530 Herman O. West Drive 19341-0645
Exton, PA, US
Exton, PA, US
CEO
Eric Green
Website
westpharma.com
IPO
1980-03-17
CIK 105770 ISIN US9553061055
Description
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
News Sentiment (7d)
3 articles
- Top 50 High-Quality Dividend Growth Stocks For July 2026 Seeking Alpha
- 5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2020-05-21 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD357.52
-2.18 (-0.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
855.4K
Beta
1.18
Float Shares
70.20M
Free Float %
99.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.31% | +1.32% | +8.47% | +26.92% | +16.43% | +17.33% | +54.17% | -3.53% | -5.10% | +329.95% | +28,981.98% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
357.52
Low
295.00
-17.5%
Consensus
315.83
-11.7%
Median
315.00
-11.9%
High
340.00
-4.9%
DCF (Unlevered)
95.51
-73.3%
DCF (Levered)
101.25
-71.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
80% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 10 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
312.50
-12.6%
|
| Last Year | 16 |
315.06
-11.9%
|
| All Time | 20 |
323.50
-9.5%
|
Quality scores
Altman Z-Score
15.37
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+6.3% Q1'26: +21.0% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+1.6% Q1'26: +56.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+18.1% Q1'26: +5.6% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+19.5% ★ Q1'26: +20.6% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+17.2% ★ Q1'26: +18.8% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-1.4% ★ Q1'26: -0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.58× ★ Q1'26: 0.45× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2000 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 9 EPS Ana. |
Dec 2027 11 Rev. Ana. 9 EPS Ana. |
Dec 2028 8 Rev. Ana. 2 EPS Ana. |
Dec 2029 7 Rev. Ana. 1 EPS Ana. |
Dec 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
430.10M
est: 543.37M (-20.8%)
|
419.70M
est: 448.02M (-6.3%)
|
490.70M
est: 444.68M (+10.4%)
|
541.60M
est: 480.44M (+12.7%)
|
699.70M
est: 736.88M (-5.0%)
|
913.30M
est: 827.52M (+10.4%)
|
1.02B
est: 968.53M (+5.3%)
|
1.05B
est: 1.04B (+0.8%)
|
1.06B
est: 1.04B (+1.9%)
|
1.10B
est: 1.07B (+3.3%)
|
1.19B
est: 1.20B (-0.7%)
|
1.27B
est: 1.11B (+14.4%)
|
1.37B
est: 1.32B (+3.8%)
|
1.42B
est: 1.41B (+0.6%)
|
1.40B
est: 1.40B (-0.5%)
|
1.51B
est: 1.51B (-0.3%)
|
1.60B
est: 1.60B (+0.1%)
|
1.72B
est: 1.73B (-0.5%)
|
1.84B
est: 1.82B (+1.2%)
|
2.15B
est: 2.10B (+2.2%)
|
2.83B
est: 2.81B (+0.7%)
|
2.89B
est: 2.84B (+1.8%)
|
2.95B
est: 2.88B (+2.6%)
|
2.89B
est: 2.88B (+0.3%)
|
3.07B
est: 3.06B (+0.3%)
|
3.33B
3.26B – 3.36B
+8.7% YoY
|
3.53B
3.46B – 3.60B
+6.1% YoY
|
3.77B
3.76B – 3.78B
+6.7% YoY
|
4.05B
3.98B – 4.14B
+7.6% YoY
|
4.11B
4.03B – 4.19B
+1.4% YoY
|
| EBITDA |
75.90M
est: 584.8K (+12,877.7%)
|
82.80M
est: 59.33M (+39.6%)
|
84.80M
est: 74.47M (+13.9%)
|
94.50M
est: 55.93M (+69.0%)
|
122.90M
est: 93.41M (+31.6%)
|
149.90M
est: 129.26M (+16.0%)
|
157.50M
est: 134.77M (+16.9%)
|
186.10M
est: 163.10M (+14.1%)
|
166.40M
est: 164.71M (+1.0%)
|
161.30M
est: 159.82M (+0.9%)
|
183.40M
est: 193.70M (-5.3%)
|
200.00M
est: 172.79M (+15.7%)
|
252.20M
est: 244.69M (+3.1%)
|
278.50M
est: 276.86M (+0.6%)
|
217.70M
est: 213.69M (+1.9%)
|
286.90M
est: 292.80M (-2.0%)
|
326.20M
est: 266.66M (+22.3%)
|
353.20M
est: 350.56M (+0.8%)
|
403.20M
est: 348.84M (+15.6%)
|
518.90M
est: 410.38M (+26.4%)
|
879.70M
est: 685.73M (+28.3%)
|
808.10M
est: 817.30M (-1.1%)
|
844.10M
est: 787.93M (+7.1%)
|
743.80M
est: 790.10M (-5.9%)
|
723.60M
est: 839.12M (-13.8%)
|
911.92M
892.69M – 920.16M
+8.7% YoY
|
967.47M
948.34M – 986.60M
+6.1% YoY
|
1.03B
1.03B – 1.03B
+6.7% YoY
|
1.11B
1.09B – 1.13B
+7.6% YoY
|
1.13B
1.10B – 1.15B
+1.4% YoY
|
| EBIT |
45.70M
est: 42.33M (+8.0%)
|
51.60M
est: 30.84M (+67.3%)
|
79.00M
est: 50.61M (+56.1%)
|
61.30M
est: 41.29M (+48.4%)
|
75.50M
est: 70.43M (+7.2%)
|
97.20M
est: 90.33M (+7.6%)
|
100.90M
est: 88.16M (+14.4%)
|
125.50M
est: 117.94M (+6.4%)
|
98.30M
est: 94.46M (+4.1%)
|
88.10M
est: 84.39M (+4.4%)
|
107.70M
est: 110.15M (-2.2%)
|
123.10M
est: 113.02M (+8.9%)
|
167.00M
est: 156.01M (+7.0%)
|
188.50M
est: 179.07M (+5.3%)
|
127.80M
est: 120.97M (+5.6%)
|
196.20M
est: 194.28M (+1.0%)
|
229.50M
est: 184.65M (+24.3%)
|
248.80M
est: 233.14M (+6.7%)
|
299.80M
est: 250.59M (+19.6%)
|
409.80M
est: 311.35M (+31.6%)
|
757.40M
est: 573.36M (+32.1%)
|
687.50M
est: 683.94M (+0.5%)
|
706.80M
est: 658.05M (+7.4%)
|
588.40M
est: 659.87M (-10.8%)
|
599.20M
est: 700.80M (-14.5%)
|
761.61M
745.55M – 768.49M
+8.7% YoY
|
808.00M
792.02M – 823.98M
+6.1% YoY
|
861.77M
859.62M – 863.92M
+6.7% YoY
|
927.23M
909.81M – 946.35M
+7.6% YoY
|
940.11M
922.45M – 959.49M
+1.4% YoY
|
| Net Income |
1.60M
est: -589.4K (+371.5%)
|
18.40M
est: 19.56M (-5.9%)
|
31.90M
est: 29.50M (+8.1%)
|
19.40M
est: 17.33M (+11.9%)
|
45.60M
est: 44.22M (+3.1%)
|
67.10M
est: 60.05M (+11.7%)
|
70.70M
est: 66.12M (+6.9%)
|
86.00M
est: 81.83M (+5.1%)
|
72.60M
est: 70.16M (+3.5%)
|
65.30M
est: 61.14M (+6.8%)
|
75.50M
est: 75.81M (-0.4%)
|
80.70M
est: 67.13M (+20.2%)
|
112.30M
est: 107.86M (+4.1%)
|
127.10M
est: 125.04M (+1.6%)
|
95.60M
est: 90.22M (+6.0%)
|
143.60M
est: 141.64M (+1.4%)
|
150.70M
est: 111.05M (+35.7%)
|
206.90M
est: 200.30M (+3.3%)
|
241.70M
est: 204.16M (+18.4%)
|
346.20M
est: 264.28M (+31.0%)
|
661.80M
est: 503.69M (+31.4%)
|
585.90M
est: 609.47M (-3.9%)
|
593.40M
est: 524.90M (+13.1%)
|
492.70M
est: 480.61M (+2.5%)
|
493.70M
est: 515.82M (-4.3%)
|
625.02M
619.55M – 630.48M
+21.2% YoY
|
689.51M
677.03M – 714.40M
+10.3% YoY
|
770.78M
728.59M – 832.10M
+11.8% YoY
|
891.53M
869.76M – 915.43M
+15.7% YoY
|
904.39M
882.31M – 928.63M
+1.4% YoY
|
| SGA |
67.70M
est: 80.71M (-16.1%)
|
82.60M
est: 86.05M (-4.0%)
|
111.00M
est: 99.77M (+11.3%)
|
97.20M
est: 92.76M (+4.8%)
|
112.40M
est: 121.78M (-7.7%)
|
144.80M
est: 139.01M (+4.2%)
|
152.50M
est: 143.66M (+6.2%)
|
159.30M
est: 156.37M (+1.9%)
|
177.70M
est: 172.76M (+2.9%)
|
187.70M
est: 181.06M (+3.7%)
|
191.10M
est: 191.95M (-0.4%)
|
218.10M
est: 185.98M (+17.3%)
|
234.90M
est: 225.94M (+4.0%)
|
228.70M
est: 226.69M (+0.9%)
|
233.00M
est: 232.54M (+0.2%)
|
239.80M
est: 234.17M (+2.4%)
|
246.00M
est: 198.62M (+23.9%)
|
262.90M
est: 255.51M (+2.9%)
|
272.70M
est: 230.90M (+18.1%)
|
302.00M
est: 230.72M (+30.9%)
|
361.90M
est: 280.25M (+29.1%)
|
316.90M
est: 329.62M (-3.9%)
|
353.40M
est: 346.57M (+2.0%)
|
338.50M
est: 347.53M (-2.6%)
|
393.10M
est: 369.09M (+6.5%)
|
401.11M
392.65M – 404.74M
+8.7% YoY
|
425.54M
417.13M – 433.96M
+6.1% YoY
|
453.86M
452.73M – 454.99M
+6.7% YoY
|
488.33M
479.17M – 498.41M
+7.6% YoY
|
495.12M
485.82M – 505.33M
+1.4% YoY
|
| EPS |
0.03
est: 0.44 (-94.3%)
|
0.33
est: 0.38 (-13.2%)
|
0.75
est: 0.36 (+108.3%)
|
0.57
est: 0.43 (+32.6%)
|
0.75
est: 0.72 (+4.2%)
|
1.05
est: 0.81 (+29.6%)
|
1.08
est: 1.06 (+1.9%)
|
1.33
est: 1.12 (+18.8%)
|
1.11
est: 1.01 (+9.9%)
|
0.98
est: 0.97 (+1.0%)
|
1.12
est: 1.20 (-6.7%)
|
1.19
est: 1.01 (+17.8%)
|
1.61
est: 1.52 (+5.9%)
|
1.79
est: 1.75 (+2.3%)
|
1.33
est: 1.83 (-27.4%)
|
1.96
est: 2.21 (-11.1%)
|
2.04
est: 2.77 (-26.4%)
|
2.80
est: 2.80 (-0.1%)
|
3.27
est: 3.14 (+4.1%)
|
4.68
est: 4.54 (+3.1%)
|
8.90
est: 8.49 (+4.8%)
|
7.88
est: 8.17 (-3.6%)
|
7.99
est: 7.12 (+12.3%)
|
6.75
est: 6.63 (+1.8%)
|
6.83
est: 7.10 (-3.7%)
|
8.62
8.52 – 8.67
+21.5% YoY
|
9.57
9.31 – 9.83
+11.0% YoY
|
10.73
10.02 – 11.45
+12.1% YoY
|
12.26
11.96 – 12.59
+14.2% YoY
|
12.44
12.14 – 12.77
+1.4% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-29 | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
| 2026-04-27 | Barclays | Equal Weight | Equal Weight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
588.96M
OE per share TTM
8.11
Owner's Yield
2.53%
Maintenance CapEx ratio
11.85%
Maint CapEx / Avg PPE
40.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
764
Total invested
17.76B
Insider transactions (90d)
15
Beneficial owners (>5%)
14
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 8.63M | 11.65% | — | 125.5K | 8.33M | 306.0K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 2 | (1) BlackRock, Inc. | 8.09M | 10.90% | 7.18M | — | 8.09M | — | HC | Delaware | 2022-01-27 | ↗ |
| 3 | 52-0556948 | 6.24M | 8.40% | 1.51M | — | 6.24M | — | IA | Maryland | 2022-02-14 | ↗ |
| 4 | Neuberger Berman LLC | 5.61M | 7.90% | — | 5.59M | — | 5.61M | BD, IA | Delaware | 2015-02-12 | ↗ |
| 5 | Neuberger Berman Management LLC | 4.82M | 6.79% | — | 4.82M | — | 4.82M | BD | Delaware | 2015-02-12 | ↗ |
| 6 | Franklin Resources, Inc. | 4.80M | 6.50% | 4.00 | 4.00 | 4.00 | 4.00 | HC, CO | Delaware | 2019-01-28 | ↗ |
| 7 | Neuberger Berman Equity Funds | 4.29M | 6.04% | — | 4.29M | — | 4.29M | IV | Delaware | 2015-02-12 | ↗ |
| 8 | Neuberger Berman Group LLC | 3.41M | 4.59% | — | 3.39M | — | 3.41M | HC | Delaware | 2018-02-15 | ↗ |
| 9 | Neuberger Berman Investment Advisers LLC | 3.41M | 4.59% | — | 3.39M | — | 3.41M | IA | Delaware | 2018-02-15 | ↗ |
| 10 | ALLIANZ GLOBAL INVESTORS CAPITAL LLC | 1.74M | 5.20% | — | — | — | — | IA, HC, OO | Delaware | 2012-02-13 | ↗ |
| 11 | LLC | 1.70M | 5.10% | — | — | — | — | IA, OO | Delaware | 2010-02-12 | ↗ |
| 12 | ALLIANZ GLOBAL INVESTORS U.S. HOLDINGS LLC | 4.2K | 0.00% | — | — | — | — | HC, OO | Delaware | 2013-02-14 | ↗ |
| 13 | Munder Capital Management | — | 0.00% | — | — | — | — | IA | State of Delaware | 2011-02-14 | ↗ |
| 14 | NFJ INVESTMENT GROUP LLC | — | 0.00% | — | — | — | — | IA, OO | Delaware | 2013-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
764
-57 vs prev Q
New positions
89
Closed positions
141
Increased
355
Reduced
275
Put/Call ratio
2.29
Calls held
216.2K
Puts held
495.5K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 9.54M -165.8K (-1.7%) | 2.62B +78.7M (+3.1%) | 13.19% -0.229 pp | 0.04% 0.000 pp | USD110.83 +148.3% | 84 qtrs — |
| 2 | BLACKROCK, INC. | 6.60M +143.9K (+2.2%) | 1.82B +122.3M (+7.2%) | 9.13% +0.199 pp | 0.03% +0.001 pp | USD300.24 -8.4% | 6 qtrs — |
| 3 | STATE STREET CORP | 3.25M +44.1K (+1.4%) | 894.76M +53.2M (+6.3%) | 4.50% +0.061 pp | 0.03% +0.001 pp | USD130.45 +110.9% | 51 qtrs — |
| 4 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.85M +79.5K (+2.9%) | 784.26M +57.4M (+7.9%) | 3.94% +0.110 pp | 1.17% +0.143 pp | USD288.41 -4.6% | 34 qtrs — |
| 5 | BANK OF NEW YORK MELLON CORP | 2.66M -242.7K (-8.4%) | 732.43M -29.6M (-3.9%) | 3.68% -0.336 pp | 0.13% -0.018 pp | USD233.99 +17.6% | 66 qtrs — |
| 6 | BROWN ADVISORY INC | 1.94M -554.5K (-22.2%) | 534.77M -120.6M (-18.4%) | 2.69% -0.767 pp | 0.75% -0.107 pp | USD273.38 +0.6% | 36 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.87M +12.0K (+0.6%) | 512.25M +27.1M (+5.6%) | 2.59% +0.017 pp | 0.03% +0.001 pp | USD189.37 +45.3% | 78 qtrs — |
| 8 | GENERATION INVESTMENT MANAGEMENT LLP | 1.56M +585.9K (+60.0%) | 429.73M +173.7M (+67.8%) | 2.16% +0.810 pp | 2.98% +1.285 pp | USD239.93 +14.7% | 3 qtrs — |
| 9 | MORGAN STANLEY | 1.53M +53.2K (+3.6%) | 421.48M +33.6M (+8.7%) | 2.12% +0.074 pp | 0.03% +0.002 pp | USD288.89 -4.8% | 51 qtrs — |
| 10 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.17M +473.5K (+67.5%) | 323.28M +139.3M (+75.7%) | 1.63% +0.655 pp | 0.20% +0.092 pp | USD262.11 +5.0% | 14 qtrs — |
| 11 | LONGVIEW PARTNERS (GUERNSEY) LTD | 1.13M +778.9K (+221.2%) | 311.19M +218.8M (+236.9%) | 1.56% +1.077 pp | 3.25% +2.284 pp | USD271.15 +1.5% | 2 qtrs — |
| 12 | APG ASSET MANAGEMENT N.V. | 1.20M -214.7K (-15.2%) | 280.89M -34.7M (-11.0%) | 1.66% -0.297 pp | 0.80% -0.089 pp | USD273.80 +0.5% | 25 qtrs — |
| 13 | NORGES BANK | 988.7K +988.7K (+100.0%) | 272.04M +272.0M (+100.0%) | 1.37% +1.368 pp | 0.03% +0.029 pp | USD275.14 +0.0% | 1 qtrs NEW |
| 14 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 955.1K -82.9K (-8.0%) | 262.80M -9.5M (-3.5%) | 1.32% -0.115 pp | 0.71% +0.042 pp | USD258.21 +6.6% | 38 qtrs — |
| 15 | INVESCO LTD. | 908.6K +27.3K (+3.1%) | 250.00M +18.8M (+8.1%) | 1.26% +0.038 pp | 0.04% +0.002 pp | USD278.91 -1.4% | 57 qtrs — |
| 16 | UBS ASSET MANAGEMENT AMERICAS INC | 905.7K +20.4K (+2.3%) | 249.18M +17.0M (+7.3%) | 1.25% +0.028 pp | 0.05% +0.002 pp | USD264.11 +4.2% | 52 qtrs — |
| 17 | FRANKLIN RESOURCES INC | 888.3K -77.7K (-8.0%) | 244.39M -9.0M (-3.6%) | 1.23% -0.107 pp | 0.06% -0.003 pp | USD104.54 +163.2% | 51 qtrs — |
| 18 | NORTHERN TRUST CORP | 726.5K -18.4K (-2.5%) | 199.89M +4.5M (+2.3%) | 1.00% -0.025 pp | 0.03% +0.001 pp | USD168.87 +62.9% | 51 qtrs — |
| 19 | VAN ECK ASSOCIATES CORP | 716.1K -708.8K (-49.7%) | 197.03M -176.8M (-47.3%) | 0.99% -0.980 pp | 0.16% -0.184 pp | USD271.85 +1.2% | 23 qtrs — |
| 20 | FINDLAY PARK PARTNERS LLP | 666.9K -135.2K (-16.9%) | 183.50M -26.9M (-12.8%) | 0.92% -0.187 pp | 2.34% +0.131 pp | USD324.54 -15.2% | 13 qtrs — |
| 21 | JACOBS LEVY EQUITY MANAGEMENT, INC | 639.6K +229.9K (+56.1%) | 175.97M +68.5M (+63.7%) | 0.88% +0.318 pp | 0.68% +0.253 pp | USD243.71 +12.9% | 4 qtrs — |
| 22 | TD ASSET MANAGEMENT INC | 605.7K -606.0 (-0.1%) | 166.66M +7.6M (+4.8%) | 0.84% -0.001 pp | 0.13% +0.005 pp | USD294.16 -6.5% | 44 qtrs — |
| 23 | SEI INVESTMENTS CO | 591.8K +64.2K (+12.2%) | 162.82M +24.4M (+17.7%) | 0.82% +0.089 pp | 0.16% +0.012 pp | USD300.47 -8.4% | 41 qtrs — |
| 24 | PROSHARE ADVISORS LLC | 586.8K -25.8K (-4.2%) | 161.47M +756.5K (+0.5%) | 0.81% -0.036 pp | 0.29% -0.051 pp | USD272.89 +0.8% | 72 qtrs — |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 542.8K +15.6K (+3.0%) | 149.35M +11.1M (+8.0%) | 0.75% +0.022 pp | 0.02% +0.001 pp | USD179.13 +53.6% | 100 qtrs — |
| 26 | BANK OF AMERICA CORP /DE/ | 531.8K +57.6K (+12.2%) | 146.33M +21.9M (+17.6%) | 0.74% +0.080 pp | 0.01% +0.002 pp | USD238.02 +15.6% | 52 qtrs — |
| 27 | AQR CAPITAL MANAGEMENT LLC | 517.6K -28.2K (-5.2%) | 142.42M -528.3K (-0.4%) | 0.72% -0.039 pp | 0.07% -0.017 pp | USD253.79 +8.4% | 45 qtrs — |
| 28 | EPOCH INVESTMENT PARTNERS, INC. | 505.3K -20.6K (-3.9%) | 139.03M +1.1M (+0.8%) | 0.70% -0.029 pp | 0.79% +0.032 pp | USD286.97 -4.1% | 22 qtrs — |
| 29 | LEGAL & GENERAL GROUP PLC | 502.7K -5.9K (-1.2%) | 138.31M +4.9M (+3.7%) | 0.70% -0.008 pp | 0.03% +0.001 pp | USD224.95 +22.3% | 46 qtrs — |
| 30 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 475.4K +16.4K (+3.6%) | 130.79M +10.4M (+8.6%) | 0.66% +0.023 pp | 1.32% +0.416 pp | USD280.04 -1.7% | 13 qtrs — |
| 31 | AMERICAN CENTURY COMPANIES INC | 445.5K +148.5K (+50.0%) | 122.57M +44.7M (+57.3%) | 0.62% +0.205 pp | 0.06% +0.022 pp | USD289.04 -4.8% | 25 qtrs — |
| 32 | ROYAL BANK OF CANADA | 444.9K -114.9K (-20.5%) | 122.40M -24.4M (-16.6%) | 0.62% -0.159 pp | 0.02% -0.004 pp | USD237.33 +15.9% | 51 qtrs — |
| 33 | BILL & MELINDA GATES FOUNDATION TRUST | 444.5K +— (+0.0%) | 122.30M +5.7M (+4.9%) | 0.61% +0.000 pp | 0.35% +0.027 pp | USD223.88 +22.9% | 4 qtrs — |
| 34 | GOLDMAN SACHS GROUP INC | 440.0K +22.0K (+5.3%) | 121.07M +11.4M (+10.4%) | 0.61% +0.030 pp | 0.01% +0.001 pp | USD246.03 +11.8% | 73 qtrs — |
| 35 | DIMENSIONAL FUND ADVISORS LP | 437.4K +56.5K (+14.8%) | 120.34M +20.4M (+20.4%) | 0.60% +0.078 pp | 0.03% +0.004 pp | USD155.80 +76.6% | 51 qtrs — |
| 36 | STEADFAST CAPITAL MANAGEMENT LP | 429.9K -41.5K (-8.8%) | 118.28M -5.4M (-4.4%) | 0.59% -0.057 pp | 2.03% -0.129 pp | USD262.33 +4.9% | 2 qtrs — |
| 37 | NEUBERGER BERMAN GROUP LLC | 427.5K -17.9K (-4.0%) | 117.63M +785.2K (+0.7%) | 0.59% -0.025 pp | 0.09% +0.002 pp | USD67.38 +308.3% | 63 qtrs — |
| 38 | NUVEEN, LLC | 404.3K +52.2K (+14.8%) | 111.25M +18.9M (+20.4%) | 0.56% +0.072 pp | 0.03% +0.005 pp | USD233.52 +17.8% | 4 qtrs — |
| 39 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 388.2K +— (+0.0%) | 106.82M +5.0M (+4.9%) | 0.54% +0.000 pp | 0.08% -0.001 pp | USD262.25 +4.9% | 43 qtrs — |
| 40 | DEUTSCHE BANK AG\ | 372.9K +26.6K (+7.7%) | 102.59M +11.7M (+12.9%) | 0.52% +0.037 pp | 0.03% +0.003 pp | USD285.36 -3.6% | 50 qtrs — |
| 41 | LIONTRUST INVESTMENT PARTNERS LLP | 366.2K -55.4K (-13.1%) | 100.75M +8.5M (+9.2%) | 0.51% -0.077 pp | 1.50% +0.198 pp | USD289.59 -5.0% | 7 qtrs — |
| 42 | AMUNDI | 347.4K +63.0K (+22.1%) | 95.59M +19.3M (+25.4%) | 0.48% +0.087 pp | 0.03% +0.002 pp | USD277.84 -1.0% | 19 qtrs — |
| 43 | PRICE T ROWE ASSOCIATES INC /MD/ | 339.3K +224.7K (+196.2%) | 93.35M +63.3M (+210.6%) | 0.47% +0.311 pp | 0.01% +0.007 pp | USD251.79 +9.3% | 75 qtrs — |
| 44 | DF DENT & CO INC | 319.6K -64.1K (-16.7%) | 87.93M -12.7M (-12.6%) | 0.44% -0.089 pp | 1.27% -0.035 pp | USD324.26 -15.1% | 13 qtrs — |
| 45 | RIVERBRIDGE PARTNERS LLC | 318.6K -43.9K (-12.1%) | 87.66M -7.4M (-7.8%) | 0.44% -0.061 pp | 1.64% +0.039 pp | USD162.94 +68.9% | 35 qtrs — |
| 46 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 300.4K +79.4K (+36.0%) | 82.65M +24.7M (+42.6%) | 0.42% +0.110 pp | 0.05% +0.012 pp | USD247.72 +11.1% | 4 qtrs — |
| 47 | VIKING GLOBAL INVESTORS LP | 295.0K +295.0K (+100.0%) | 81.17M +81.2M (+100.0%) | 0.41% +0.408 pp | 0.22% +0.215 pp | USD275.14 +0.0% | 1 qtrs NEW |
| 48 | SEILERN INVESTMENT MANAGEMENT LTD | 278.2K -48.7K (-14.9%) | 76.55M -9.2M (-10.7%) | 0.38% -0.067 pp | 5.94% -0.263 pp | USD327.56 -16.0% | 5 qtrs — |
| 49 | JPMORGAN CHASE & CO | 275.0K +38.0K (+16.0%) | 75.65M +13.5M (+21.7%) | 0.38% +0.053 pp | 0.00% +0.001 pp | USD289.25 -4.9% | 51 qtrs — |
| 50 | RHUMBLINE ADVISERS | 272.2K +29.3K (+12.0%) | 74.89M +11.2M (+17.5%) | 0.38% +0.041 pp | 0.06% +0.009 pp | USD180.07 +52.8% | 55 qtrs — |
| 51 | BAMCO INC /NY/ | 263.2K -37.7K (-12.5%) | 72.41M -6.5M (-8.3%) | 0.36% -0.052 pp | 0.20% -0.013 pp | USD43.12 +538.1% | 51 qtrs — |
| 52 | ASSENAGON ASSET MANAGEMENT S.A. | 251.0K +62.1K (+32.9%) | 69.06M +19.5M (+39.4%) | 0.35% +0.086 pp | 0.10% +0.027 pp | USD269.56 +2.1% | 24 qtrs — |
| 53 | UBS GROUP AG | 250.4K -44.5K (-15.1%) | 68.89M -8.5M (-10.9%) | 0.35% -0.062 pp | 0.01% -0.001 pp | USD274.74 +0.1% | 45 qtrs — |
| 54 | ENVESTNET ASSET MANAGEMENT INC | 248.1K -73.9K (-22.9%) | 68.27M -16.2M (-19.2%) | 0.34% -0.102 pp | 0.02% -0.004 pp | USD257.53 +6.8% | 51 qtrs — |
| 55 | CITADEL ADVISORS LLC | 245.6K -481.9K (-66.2%) | 67.59M -123.3M (-64.6%) | 0.34% -0.667 pp | 0.01% -0.019 pp | USD274.30 +0.3% | 52 qtrs — |
| 56 | BROWN BROTHERS HARRIMAN & CO | 240.7K -6.7K (-2.7%) | 66.22M +1.3M (+2.1%) | 0.33% -0.009 pp | 0.36% -0.034 pp | USD269.62 +2.0% | 5 qtrs — |
| 57 | BORDER TO COAST PENSIONS PARTNERSHIP LTD | 236.3K +80.6K (+51.7%) | 65.14M +24.3M (+59.4%) | 0.33% +0.111 pp | 1.13% +0.423 pp | USD266.70 +3.2% | 2 qtrs — |
| 58 | POINT72 ASSET MANAGEMENT, L.P. | 235.0K -424.2K (-64.3%) | 64.67M -108.3M (-62.6%) | 0.33% -0.587 pp | 0.07% -0.217 pp | USD261.05 +5.4% | 5 qtrs — |
| 59 | JANE STREET GROUP, LLC | 219.7K +183.5K (+506.3%) | 60.46M +51.0M (+535.9%) | 0.30% +0.254 pp | 0.01% +0.008 pp | USD265.97 +3.4% | 26 qtrs — |
| 60 | BNP PARIBAS ARBITRAGE, SNC | 213.3K +92.0K (+75.9%) | 58.70M +26.9M (+84.5%) | 0.30% +0.127 pp | 0.03% +0.010 pp | USD271.33 +1.4% | 51 qtrs — |
| 61 | LGT GROUP FOUNDATION | 205.1K -4.5K (-2.1%) | 56.78M -103.1K (-0.2%) | 0.28% -0.006 pp | 0.62% -0.033 pp | USD271.97 +1.2% | 7 qtrs — |
| 62 | FEDERATED HERMES, INC. | 200.1K -27.5K (-12.1%) | 55.05M -4.6M (-7.8%) | 0.28% -0.038 pp | 0.09% -0.013 pp | USD193.71 +42.0% | 42 qtrs — |
| 63 | SWISS NATIONAL BANK | 197.0K -10.1K (-4.9%) | 54.21M -115.0K (-0.2%) | 0.27% -0.014 pp | 0.03% +0.001 pp | USD166.53 +65.2% | 51 qtrs — |
| 64 | SCHRODER INVESTMENT MANAGEMENT GROUP | 179.2K +28.9K (+19.2%) | 49.61M +10.2M (+25.8%) | 0.25% +0.040 pp | 0.04% +0.007 pp | USD246.99 +11.4% | 51 qtrs — |
| 65 | CBOE VEST FINANCIAL, LLC | 178.1K -18.4K (-9.4%) | 49.00M -2.5M (-4.9%) | 0.25% -0.025 pp | 0.62% -0.052 pp | USD299.15 -8.0% | 20 qtrs — |
| 66 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 176.1K -12.4K (-6.6%) | 48.46M -991.3K (-2.0%) | 0.24% -0.017 pp | 0.03% +0.000 pp | USD193.19 +42.4% | 25 qtrs — |
| 67 | RUSSELL INVESTMENTS GROUP, LTD. | 172.1K +34.7K (+25.3%) | 47.37M +11.3M (+31.5%) | 0.24% +0.048 pp | 0.05% +0.011 pp | USD233.50 +17.8% | 37 qtrs — |
| 68 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 167.2K +2.1K (+1.3%) | 46.21M +2.9M (+6.7%) | 0.23% +0.003 pp | 0.03% +0.000 pp | USD280.31 -1.8% | 25 qtrs — |
| 69 | PRUDENTIAL FINANCIAL INC | 163.1K +59.7K (+57.8%) | 44.87M +17.8M (+65.5%) | 0.23% +0.083 pp | 0.05% +0.022 pp | USD276.06 -0.3% | 85 qtrs — |
| 70 | AMI ASSET MANAGEMENT CORP | 159.0K -4.0K (-2.4%) | 43.76M +998.2K (+2.3%) | 0.22% -0.006 pp | 2.48% +0.093 pp | USD196.12 +40.3% | 46 qtrs — |
| 71 | NOMURA ASSET MANAGEMENT CO LTD | 154.5K -7.2K (-4.5%) | 42.51M +85.4K (+0.2%) | 0.21% -0.010 pp | 0.11% -0.003 pp | USD274.91 +0.1% | 32 qtrs — |
| 72 | BIRCH HILL INVESTMENT ADVISORS LLC | 152.1K +15.7K (+11.5%) | 41.86M +6.1M (+16.9%) | 0.21% +0.022 pp | 1.75% +0.237 pp | USD242.81 +13.3% | 3 qtrs — |
| 73 | PICTET ASSET MANAGEMENT HOLDING SA | 152.0K -38.1K (-20.0%) | 41.82M -8.1M (-16.1%) | 0.21% -0.053 pp | 0.04% -0.008 pp | USD304.35 -9.6% | 10 qtrs — |
| 74 | HSBC HOLDINGS PLC | 146.9K +27.7K (+23.3%) | 40.43M +9.1M (+29.2%) | 0.20% +0.038 pp | 0.02% +0.003 pp | USD298.10 -7.7% | 46 qtrs — |
| 75 | BAIRD FINANCIAL GROUP, INC. | 146.2K +24.6K (+20.2%) | 40.23M +8.3M (+26.1%) | 0.20% +0.034 pp | 0.06% +0.011 pp | USD233.95 +17.6% | 21 qtrs — |
| 76 | CITIGROUP INC | 145.7K +62.9K (+76.0%) | 40.08M +18.4M (+84.6%) | 0.20% +0.087 pp | 0.02% +0.008 pp | USD265.35 +3.7% | 56 qtrs — |
| 77 | BARCLAYS PLC | 142.2K -113.0K (-44.3%) | 39.12M -37.5M (-48.9%) | 0.20% -0.156 pp | 0.01% -0.010 pp | USD287.03 -4.1% | 51 qtrs — |
| 78 | TWO SIGMA INVESTMENTS, LP | 139.9K +38.7K (+38.3%) | 38.50M +12.0M (+45.0%) | 0.19% +0.054 pp | 0.05% +0.015 pp | USD246.18 +11.8% | 15 qtrs — |
| 79 | WALLEYE CAPITAL LLC | 134.5K +109.7K (+443.7%) | 36.99M +30.5M (+470.2%) | 0.19% +0.152 pp | 0.11% +0.089 pp | USD279.02 -1.4% | 10 qtrs — |
| 80 | BANK OF MONTREAL /CAN/ | 132.6K -322.0 (-0.2%) | 36.50M +1.6M (+4.6%) | 0.18% 0.000 pp | 0.01% -0.001 pp | USD316.38 -13.0% | 51 qtrs — |
| 81 | HOLOCENE ADVISORS, LP | 127.7K -59.4K (-31.7%) | 35.14M -13.9M (-28.4%) | 0.18% -0.082 pp | 0.07% -0.038 pp | USD262.33 +4.9% | 10 qtrs — |
| 82 | HRT FINANCIAL LP | 127.2K +124.8K (+5,223.9%) | 34.99M +34.4M (+5,490.1%) | 0.18% +0.173 pp | 0.11% +0.108 pp | USD274.08 +0.4% | 3 qtrs — |
| 83 | ASSET MANAGEMENT ONE CO., LTD. | 125.0K +55.2K (+79.2%) | 34.44M +16.1M (+88.1%) | 0.17% +0.076 pp | 0.10% +0.043 pp | USD267.34 +2.9% | 25 qtrs — |
| 84 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 123.3K +830.0 (+0.7%) | 33.93M +1.8M (+5.6%) | 0.17% +0.001 pp | 0.02% +0.000 pp | USD247.72 +11.1% | 54 qtrs — |
| 85 | ANNEX ADVISORY SERVICES, LLC | 123.0K +9.8K (+8.7%) | 33.83M +4.1M (+14.0%) | 0.17% +0.014 pp | 0.65% +0.014 pp | USD279.22 -1.5% | 13 qtrs — |
| 86 | CONESTOGA CAPITAL ADVISORS, LLC | 122.8K +22.0K (+21.8%) | 33.78M +7.3M (+27.8%) | 0.17% +0.030 pp | 0.57% +0.144 pp | USD241.28 +14.0% | 36 qtrs — |
| 87 | — | 120.9K -5.5K (-4.4%) | 33.27M +98.9K (+0.3%) | 0.17% -0.008 pp | 0.59% +0.020 pp | USD311.15 -11.6% | 5 qtrs — |
| 88 | CANADA PENSION PLAN INVESTMENT BOARD | 114.4K -45.8K (-28.6%) | 31.48M -10.6M (-25.1%) | 0.16% -0.063 pp | 0.02% -0.009 pp | USD286.52 -4.0% | 28 qtrs — |
| 89 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 113.6K -3.9K (-3.4%) | 31.25M +419.7K (+1.4%) | 0.16% -0.006 pp | 0.03% 0.000 pp | USD87.96 +212.8% | 52 qtrs — |
| 90 | KOREA INVESTMENT CORP | 111.0K +54.9K (+97.8%) | 30.53M +15.8M (+107.5%) | 0.15% +0.076 pp | 0.06% +0.030 pp | USD276.60 -0.5% | 24 qtrs — |
| 91 | MILLENNIUM MANAGEMENT LLC | 110.4K -202.6K (-64.7%) | 30.37M -51.7M (-63.0%) | 0.15% -0.280 pp | 0.01% -0.022 pp | USD271.03 +1.5% | 41 qtrs — |
| 92 | NAN SHAN LIFE INSURANCE CO., LTD. | 109.9K +— (+0.0%) | 30.23M +1.4M (+4.9%) | 0.15% +0.000 pp | 0.93% +0.318 pp | USD309.32 -11.1% | 7 qtrs — |
| 93 | FMR LLC | 109.7K +65.3K (+147.2%) | 30.17M +18.5M (+159.2%) | 0.15% +0.090 pp | 0.00% +0.001 pp | USD292.94 -6.1% | 30 qtrs — |
| 94 | WELLS FARGO & COMPANY/MN | 106.7K -2.3K (-2.1%) | 29.36M +760.4K (+2.7%) | 0.15% -0.003 pp | 0.01% 0.000 pp | USD234.34 +17.4% | 57 qtrs — |
| 95 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 106.5K +22.6K (+26.9%) | 29.29M +7.3M (+33.1%) | 0.15% +0.031 pp | 0.45% +0.103 pp | USD265.05 +3.8% | 2 qtrs — |
| 96 | QUANTINNO CAPITAL MANAGEMENT LP | 105.4K +13.1K (+14.2%) | 29.00M +4.8M (+19.7%) | 0.15% +0.018 pp | 0.06% -0.008 pp | USD253.60 +8.5% | 29 qtrs — |
| 97 | RENAISSANCE TECHNOLOGIES LLC | 104.7K +104.7K (+100.0%) | 28.82M +28.8M (+100.0%) | 0.14% +0.145 pp | 0.04% +0.045 pp | USD275.14 +0.0% | 3 qtrs — |
| 98 | EULAV ASSET MANAGEMENT | 104.6K +— (+0.0%) | 28.78M +1.3M (+4.9%) | 0.14% +0.000 pp | 0.77% +0.130 pp | USD370.16 -25.7% | 12 qtrs — |
| 99 | RAYMOND JAMES FINANCIAL INC | 102.4K -18.0K (-14.9%) | 28.19M -3.4M (-10.8%) | 0.14% -0.025 pp | 0.01% -0.001 pp | USD322.37 -14.7% | 5 qtrs — |
| 100 | MACKENZIE FINANCIAL CORP | 101.9K +9.2K (+10.0%) | 28.16M +3.9M (+15.8%) | 0.14% +0.013 pp | 0.03% +0.004 pp | USD268.96 +2.3% | 25 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
0
Sells
0
Shares acquired
—
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-12-08 | Finch Norman D. Jr. | Officer | — | — | Stock Option (Right to Buy) | 459 | 269.08 | 123.5K | 0 | D | ↗ |
| 2026-08-11 | McMahon Robert W. | Officer | — | — | Stock Option (Right to Buy) | 7,137 | 240.33 | 1.72M | 0 | D | ↗ |
| 2026-05-12 | Campbell Shane Alden | Officer | M-Exempt | D | Rst. Stock Unit | 474 | 0.00 | — | 1,417 | D | ↗ |
| 2026-05-04 | Pucci Paolo | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 11,854 | D | ↗ |
| 2026-05-04 | Michels Douglas A | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 46,496 | D | ↗ |
| 2026-05-04 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 3,523 | D | ↗ |
| 2026-05-04 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 20,435 | D | ↗ |
| 2026-05-04 | Keller Deborah L | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 11,560 | D | ↗ |
| 2026-05-04 | Joseph Molly | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 4,398 | D | ↗ |
| 2026-05-04 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 2,373 | D | ↗ |
| 2026-05-04 | Feehery William F | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 32,519 | D | ↗ |
| 2026-05-04 | FRIEL ROBERT F | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 5,513 | D | ↗ |
| 2026-05-04 | BUTHMAN MARK A | Director | A-Award | A | Common Stock | 791 | 0.00 | — | 44,309 | D | ↗ |
| 2026-04-27 | Winters Chad | Officer | S-Sale | D | Common Stock | 896 | 300.67 | 269.4K | 1,523 | D | ↗ |
| 2026-04-27 | Favorite Annette F | Officer | M-Exempt | D | Stock Options (Right to Buy) | 2,817 | 83.47 | 235.1K | 5,635 | D | ↗ |
| 2026-03-31 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Phantom Stock Unit | 52 | 0.00 | — | 260 | D | ↗ |
| 2026-03-01 | Winters Chad | Officer | A-Award | A | Rst. Stock Unit | 340 | 0.00 | — | 340 | D | ↗ |
| 2026-03-01 | Poussot Rodolphe Jean | Officer | A-Award | A | Rst. Stock Unit | 437 | 0.00 | — | 437 | D | ↗ |
| 2026-03-01 | McMahon Robert W. | Officer | A-Award | A | Stock Option (Right to Buy) | 7,337 | 254.34 | 1.87M | 7,337 | D | ↗ |
| 2026-03-01 | Green Eric Mark | Director / Officer | A-Award | A | Rst. Stock Unit | 6,986 | 0.00 | — | 6,986 | D | ↗ |
| 2026-03-01 | Finch Norman D. Jr. | Officer | A-Award | A | Stock Option (Right to Buy) | 3,057 | 254.34 | 777.5K | 3,057 | D | ↗ |
| 2026-03-01 | Favorite Annette F | Officer | A-Award | A | Rst. Stock Unit | 720 | 0.00 | — | 720 | D | ↗ |
| 2026-03-01 | Campbell Shane Alden | Officer | A-Award | A | Stock Option (Right to Buy) | 2,691 | 254.34 | 684.4K | 2,691 | D | ↗ |
| 2026-02-20 | Witherspoon Charles | Officer | M-Exempt | D | Rst. Stock Unit | 60 | 0.00 | — | 178 | D | ↗ |
| 2026-02-20 | Winters Chad | Officer | F-InKind | D | Common Stock | 30 | 241.12 | 7.3K | 1,523 | D | ↗ |
| 2026-02-20 | Poussot Rodolphe Jean | Officer | M-Exempt | D | Rst. Stock Unit | 383 | 0.00 | — | 383 | D | ↗ |
| 2026-02-18 | Poussot Rodolphe Jean | Officer | M-Exempt | A | Common Stock | 82 | 0.00 | — | 335 | D | ↗ |
| 2026-02-18 | Green Eric Mark | Director / Officer | M-Exempt | A | Common Stock | 1,319 | 0.00 | — | 175,734 | D | ↗ |
| 2026-02-18 | Favorite Annette F | Officer | M-Exempt | A | Common Stock | 135 | 0.00 | — | 17,410 | D | ↗ |
| 2026-02-17 | Witherspoon Charles | Officer | F-InKind | D | Common Stock | 42 | 243.19 | 10.1K | 1,370 | D | ↗ |
| 2026-02-17 | Winters Chad | Officer | A-Award | A | Common Stock | 150 | 0.00 | — | 1,513 | D | ↗ |
| 2026-02-17 | Green Eric Mark | Director / Officer | F-InKind | D | Common Stock | 1,305 | 243.19 | 317.5K | 172,895 | D | ↗ |
| 2026-02-17 | Favorite Annette F | Officer | F-InKind | D | Common Stock | 150 | 243.19 | 36.6K | 17,275 | D | ↗ |
| 2026-02-11 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 1,250 | 246.16 | 307.7K | 2,980 | D | ↗ |
| 2025-12-31 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Phantom Stock Unit | 46 | 0.00 | — | 208 | D | ↗ |
| 2025-12-09 | Finch Norman D. Jr. | Officer | — | — | Rst. Stock Unit | 192 | 0.00 | — | 0 | D | ↗ |
| 2025-12-08 | Finch Norman D. Jr. | Officer | A-Award | A | Stock Option (Right to Buy) | 459 | 269.08 | 123.5K | 459 | D | ↗ |
| 2025-09-30 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Phantom Stock Unit | 48 | 0.00 | — | 162 | D | ↗ |
| 2025-08-11 | McMahon Robert W. | Officer | A-Award | A | Rst. Stock Unit | 12,670 | 0.00 | — | 12,670 | D | ↗ |
| 2025-08-04 | McMahon Robert W. | Officer | — | — | Rst. Stock Unit | 12,670 | 0.00 | — | 0 | D | ↗ |
| 2025-07-23 | Poussot Rodolphe Jean | Officer | — | — | Rst. Stock Unit | 329 | 0.00 | — | 0 | D | ↗ |
| 2025-06-30 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Phantom Stock Unit | 58 | 0.00 | — | 114 | D | ↗ |
| 2025-05-12 | Campbell Shane Alden | Officer | A-Award | A | Rst. Stock Unit | 1,891 | 0.00 | — | 1,891 | D | ↗ |
| 2025-05-06 | Pucci Paolo | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 10,947 | D | ↗ |
| 2025-05-06 | Michels Douglas A | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 45,171 | D | ↗ |
| 2025-05-06 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 2,708 | D | ↗ |
| 2025-05-06 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 19,424 | D | ↗ |
| 2025-05-06 | Keller Deborah L | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 10,657 | D | ↗ |
| 2025-05-06 | Joseph Molly | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 2,884 | D | ↗ |
| 2025-05-06 | Hofmann Thomas W | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 44,637 | D | ↗ |
| 2025-05-06 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 1,318 | D | ↗ |
| 2025-05-06 | Feehery William F | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 31,363 | D | ↗ |
| 2025-05-06 | FRIEL ROBERT F | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 4,682 | D | ↗ |
| 2025-05-06 | BUTHMAN MARK A | Director | A-Award | A | Common Stock | 1,071 | 0.00 | — | 42,861 | D | ↗ |
| 2025-05-05 | Campbell Shane Alden | Officer | — | — | Rst. Stock Unit | 1,182 | 0.00 | — | 0 | D | ↗ |
| 2025-03-31 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Phantom Stock Unit | 56 | 0.00 | — | 56 | D | ↗ |
| 2025-02-20 | Poussot Rodolphe Jean | Officer | — | — | Stock Option (Right to Buy) | 1,577 | 350.18 | 552.2K | 0 | D | ↗ |
| 2025-02-18 | Witherspoon Charles | Officer | A-Award | A | Rst. Stock Unit | 237 | 0.00 | — | 237 | D | ↗ |
| 2025-02-18 | Winters Chad | Officer | A-Award | A | Rst. Stock Unit | 356 | 0.00 | — | 356 | D | ↗ |
| 2025-02-18 | Reiss-Clark Cindy | Officer | M-Exempt | A | Common Stock | 246 | 211.00 | 51.9K | 5,131 | D | ↗ |
| 2025-02-18 | MacKay Kimberly Banks | Officer | A-Award | A | Rst. Stock Unit | 503 | 0.00 | — | 503 | D | ↗ |
| 2025-02-18 | Green Eric Mark | Director / Officer | A-Award | A | Rst. Stock Unit | 5,256 | 0.00 | — | 5,256 | D | ↗ |
| 2025-02-18 | Favorite Annette F | Officer | M-Exempt | A | Common Stock | 246 | 211.00 | 51.9K | 6,823 | D | ↗ |
| 2025-02-18 | Birkett Bernard | Officer | A-Award | A | Rst. Stock Unit | 1,740 | 0.00 | — | 1,740 | D | ↗ |
| 2024-12-16 | HAUGEN JANET BRUTSCHEA | Director | A-Award | A | Common Stock | 247 | 0.00 | — | 247 | D | ↗ |
| 2024-12-09 | HAUGEN JANET BRUTSCHEA | Director | — | — | Common Stock | 0 | 0.00 | — | 247 | D | ↗ |
| 2024-10-29 | Witherspoon Charles | Officer | M-Exempt | D | Stock Options (Right to Buy) | 478 | 173.22 | 82.8K | 0 | D | ↗ |
| 2024-10-29 | Abraham Silji | Officer | M-Exempt | D | Rst. Stock Unit | 458 | 0.00 | — | 0 | D | ↗ |
| 2024-08-19 | Witherspoon Charles | Officer | M-Exempt | A | Common Stock | 529 | 102.51 | 54.2K | 2,507 | — | ↗ |
| 2024-08-06 | Green Eric Mark | Director / Officer | S-Sale | D | Common Stock | 30,732 | 304.71 | 9.36M | 161,898 | — | ↗ |
| 2024-06-12 | Abraham Silji | Officer | S-Sale | D | Common Stock | 1,800 | 330.78 | 595.4K | 2,860 | — | ↗ |
| 2024-05-10 | Hofmann Thomas W | Director | S-Sale | D | Common Stock | 617 | 365.92 | 225.8K | 43,565 | — | ↗ |
| 2024-05-07 | Green Eric Mark | Director / Officer | M-Exempt | A | Common Stock | 9,000 | 59.64 | 536.8K | 161,908 | — | ↗ |
| 2024-04-23 | Pucci Paolo | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 9,876 | — | ↗ |
| 2024-04-23 | Michels Douglas A | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 44,100 | — | ↗ |
| 2024-04-23 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 1,634 | — | ↗ |
| 2024-04-23 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 18,353 | — | ↗ |
| 2024-04-23 | Keller Deborah L | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 9,586 | — | ↗ |
| 2024-04-23 | Joseph Molly | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 1,812 | — | ↗ |
| 2024-04-23 | Hofmann Thomas W | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 44,180 | — | ↗ |
| 2024-04-23 | Feehery William F | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 30,292 | — | ↗ |
| 2024-04-23 | FRIEL ROBERT F | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 3,611 | — | ↗ |
| 2024-04-23 | BUTHMAN MARK A | Director | A-Award | A | Common Stock | 564 | 0.00 | — | 41,786 | — | ↗ |
| 2024-03-11 | Winters Chad | Officer | M-Exempt | A | Common Stock | 675 | 173.22 | 116.9K | 2,124 | — | ↗ |
| 2024-02-28 | Witherspoon Charles | Officer | M-Exempt | D | Stock Options (Right to Buy) | 2,019 | 102.51 | 207.0K | 529 | — | ↗ |
| 2024-02-27 | Green Eric Mark | Director / Officer | M-Exempt | A | Common Stock | 9,000 | 57.38 | 516.4K | 152,908 | — | ↗ |
| 2024-02-23 | Abraham Silji | Officer | M-Exempt | D | Stock Options (Right to Buy) | 7,012 | 173.22 | 1.21M | 0 | — | ↗ |
| 2024-02-20 | Witherspoon Charles | Officer | A-Award | A | Common Stock | 144 | 0.00 | — | 1,979 | — | ↗ |
| 2024-02-20 | Winters Chad | Officer | A-Award | A | Stock Options (Right to Buy) | 1,020 | 350.18 | 357.2K | 1,020 | — | ↗ |
| 2024-02-20 | Reiss-Clark Cindy | Officer | A-Award | A | Stock Options (Right to Buy) | 2,411 | 350.18 | 844.3K | 2,411 | — | ↗ |
| 2024-02-20 | MacKay Kimberly Banks | Officer | A-Award | A | Common Stock | 720 | 0.00 | — | 1,358 | — | ↗ |
| 2024-02-20 | Lai Quintin J | Officer | A-Award | A | Common Stock | 375 | 0.00 | — | 4,359 | — | ↗ |
| 2024-02-20 | Green Eric Mark | Director / Officer | A-Award | A | Common Stock | 6,567 | 0.00 | — | 148,203 | — | ↗ |
| 2024-02-20 | Favorite Annette F | Officer | A-Award | A | Stock Options (Right to Buy) | 2,597 | 350.18 | 909.4K | 2,597 | — | ↗ |
| 2024-02-20 | Birkett Bernard | Officer | A-Award | A | Stock Options (Right to Buy) | 8,346 | 350.18 | 2.92M | 8,346 | — | ↗ |
| 2024-02-20 | Abraham Silji | Officer | A-Award | A | Common Stock | 646 | 0.00 | — | 4,660 | — | ↗ |
| 2023-12-11 | Favorite Annette F | Officer | G-Gift | D | Common Stock | 584 | 0.00 | — | 5,962 | — | ↗ |
| 2023-12-06 | Green Eric Mark | Director / Officer | G-Gift | D | Common Stock | 9,800 | 343.00 | 3.36M | 130,774 | — | ↗ |
| 2023-12-04 | Winters Chad | Officer | S-Sale | D | Common Stock | 1,013 | 349.00 | 353.5K | 1,270 | — | ↗ |
| 2023-12-01 | Winters Chad | Officer | M-Exempt | D | Stock Options (Right to Buy) | 341 | 173.22 | 59.1K | 1,571 | — | ↗ |
| 2023-10-31 | Witherspoon Charles | Officer | M-Exempt | A | Common Stock | 596 | 274.29 | 163.5K | 3,025 | — | ↗ |
| 2023-08-30 | Favorite Annette F | Officer | M-Exempt | A | Common Stock | 2,000 | 83.47 | 166.9K | 16,877 | — | ↗ |
| 2023-08-22 | Reiss-Clark Cindy | Officer | S-Sale | D | Common Stock | 3,477 | 393.34 | 1.37M | 4,320 | — | ↗ |
| 2023-08-11 | Lai Quintin J | Officer | S-Sale | D | Common Stock | 8,635 | 395.54 | 3.42M | 20,048 | — | ↗ |
| 2023-08-09 | Witherspoon Charles | Officer | M-Exempt | D | Stock Options (Right to buy) | 840 | 102.51 | 86.1K | 708 | — | ↗ |
| 2023-08-08 | Green Eric Mark | Director / Officer | S-Sale | D | Common Stock | 7,055 | 393.13 | 2.77M | 172,019 | — | ↗ |
| 2023-08-08 | Abraham Silji | Officer | M-Exempt | D | Stock Options (Right to buy) | 8,160 | 102.51 | 836.5K | 0 | — | ↗ |
| 2023-08-02 | Birkett Bernard | Officer | M-Exempt | A | Common Stock | 13,884 | 100.92 | 1.40M | 26,700 | — | ↗ |
| 2023-05-30 | Witherspoon Charles | Officer | M-Exempt | D | Stock Options (Right to buy) | 1,000 | 102.51 | 102.5K | 1,548 | — | ↗ |
| 2023-05-30 | Winters Chad | Officer | M-Exempt | A | Common Stock | 872 | 143.43 | 125.1K | 2,321 | — | ↗ |
| 2023-05-09 | Green Eric Mark | Director / Officer | M-Exempt | A | Common Stock | 50,000 | 57.38 | 2.87M | 178,574 | — | ↗ |
| 2023-05-05 | Winters Chad | Officer | F-InKind | D | Common Stock | 10 | 368.46 | 3.7K | 1,449 | — | ↗ |
| 2023-05-01 | Hofmann Thomas W | Director | S-Sale | D | Common Stock | 1,212 | 365.58 | 443.1K | 43,616 | — | ↗ |
| 2023-05-01 | Favorite Annette F | Officer | M-Exempt | D | Stock Option (Right to Buy) | 13,012 | 59.64 | 776.0K | 0 | — | ↗ |
| 2023-05-01 | Abraham Silji | Officer | M-Exempt | D | Stock Options (Right to Buy) | 8,020 | 86.24 | 691.6K | 0 | — | ↗ |
| 2023-04-25 | Pucci Paolo | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 9,312 | — | ↗ |
| 2023-04-25 | Michels Douglas A | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 43,536 | — | ↗ |
| 2023-04-25 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 1,070 | — | ↗ |
| 2023-04-25 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 17,789 | — | ↗ |
| 2023-04-25 | Keller Deborah L | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 9,022 | — | ↗ |
| 2023-04-25 | Joseph Molly | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 1,248 | — | ↗ |
| 2023-04-25 | Hofmann Thomas W | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 44,828 | — | ↗ |
| 2023-04-25 | Feehery William F | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 29,728 | — | ↗ |
| 2023-04-25 | FRIEL ROBERT F | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 3,047 | — | ↗ |
| 2023-04-25 | BUTHMAN MARK A | Director | A-Award | A | Common Stock | 616 | 0.00 | — | 41,222 | — | ↗ |
| 2023-03-09 | Abraham Silji | Officer | S-Sale | D | Common Stock | 1,500 | 322.57 | 483.9K | 4,209 | — | ↗ |
| 2023-03-07 | Green Eric Mark | — | S-Sale | D | Common Stock | 3,154 | 320.60 | 1.01M | 85,705 | — | ↗ |
| 2023-03-01 | Abraham Silji | Officer | A-Award | A | Common Stock | 234 | 318.28 | 74.5K | 5,709 | — | ↗ |
| 2023-02-22 | Witherspoon Charles | — | — | D | Stock Options (Right to buy) | 828 | 369.13 | 305.6K | 0 | — | ↗ |
| 2023-02-22 | Reiss-Clark Cindy | — | — | D | Stock Options (Right to buy) | 3,108 | 369.13 | 1.15M | 0 | — | ↗ |
| 2023-02-21 | Witherspoon Charles | — | A-Award | A | Common Stock | 407 | 306.68 | 124.8K | 1,829 | — | ↗ |
| 2023-02-21 | Winters Chad | — | A-Award | A | Stock Options (Right to buy) | 1,012 | 306.68 | 310.4K | 1,012 | — | ↗ |
| 2023-02-21 | Reiss-Clark Cindy | — | A-Award | A | Stock Options (Right to buy) | 2,988 | 306.68 | 916.4K | 2,988 | — | ↗ |
| 2023-02-21 | MacKay Kimberly Banks | — | A-Award | A | Common Stock | 327 | 306.68 | 100.3K | 637 | — | ↗ |
| 2023-02-21 | Lai Quintin J | — | A-Award | A | Stock Options (Right to buy) | 1,724 | 306.68 | 528.7K | 1,724 | — | ↗ |
| 2023-02-21 | Green Eric Mark | — | A-Award | A | Stock Options (Right to buy) | 29,872 | 306.68 | 9.16M | 29,872 | — | ↗ |
| 2023-02-21 | Favorite Annette F | — | A-Award | A | Stock Options (Right to buy) | 2,988 | 306.68 | 916.4K | 2,988 | — | ↗ |
| 2023-02-21 | Birkett Bernard | — | A-Award | A | Common Stock | 3,614 | 306.68 | 1.11M | 4,409 | — | ↗ |
| 2023-02-21 | Abraham Silji | — | A-Award | A | Stock Options (Right to buy) | 3,216 | 306.68 | 986.3K | 3,216 | — | ↗ |
| 2022-12-31 | Green Eric Mark | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-30 | Joseph Molly | Director | A-Award | A | Phantom Stock Unit | 96 | 235.35 | 22.6K | 701 | — | ↗ |
| 2022-12-05 | Green Eric Mark | Director | S-Sale | D | Common Stock | 6,312 | 238.83 | 1.51M | 136,456 | — | ↗ |
| 2022-10-31 | Winters Chad | Director | F-InKind | D | Common Stock | 47 | 225.51 | 10.6K | 983 | — | ↗ |
| 2022-09-30 | Joseph Molly | Director | A-Award | A | Phantom Stock Unit | 91 | 246.08 | 22.4K | 605 | — | ↗ |
| 2022-08-02 | Birkett Bernard | Director | S-Sale | D | Common Stock | 1,100 | 343.38 | 377.7K | 795 | — | ↗ |
| 2022-08-01 | Lockhart Stephen H | Director | A-Award | A | Common Stock | 454 | 0.00 | — | 454 | — | ↗ |
| 2022-08-01 | Abraham Silji | Director / Officer | S-Sale | D | Common Stock | 5,374 | 343.93 | 1.85M | 3,201 | — | ↗ |
| 2022-07-27 | Lockhart Stephen H | — | — | D | Common Stock | 0 | 0.00 | — | 454 | — | ↗ |
| 2022-06-30 | Joseph Molly | Director | A-Award | A | Phantom Stock Unit | 74 | 302.37 | 22.4K | 205 | — | ↗ |
| 2022-06-21 | Birkett Bernard | Director | F-InKind | D | Common Stock | 946 | 288.53 | 272.9K | 14,969 | — | ↗ |
| 2022-05-24 | Pucci Paolo | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 8,696 | — | ↗ |
| 2022-05-24 | Michels Douglas A | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 42,920 | — | ↗ |
| 2022-05-24 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 17,173 | — | ↗ |
| 2022-05-24 | Keller Deborah L | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 8,406 | — | ↗ |
| 2022-05-24 | Joseph Molly | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 940 | — | ↗ |
| 2022-05-24 | Hofmann Thomas W | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 44,212 | — | ↗ |
| 2022-05-24 | Feehery William F | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 29,112 | — | ↗ |
| 2022-05-24 | FRIEL ROBERT F | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 2,431 | — | ↗ |
| 2022-05-24 | BUTHMAN MARK A | Director | A-Award | A | Common Stock | 632 | 0.00 | — | 40,606 | — | ↗ |
| 2022-05-23 | Birkett Bernard | Director | A-Award | A | Stock Options (Right to buy) | 1,344 | 0.00 | — | 1,344 | — | ↗ |
| 2022-05-05 | Winters Chad | Director | F-InKind | D | Common Stock | 10 | 314.76 | 3.1K | 1,063 | — | ↗ |
| 2022-03-31 | ZENNER PATRICK J | Director | A-Award | A | Phantom Stock Unit | 49 | 410.71 | 20.1K | 10,928 | — | ↗ |
| 2022-03-31 | Joseph Molly | Director | A-Award | A | Phantom Stock Unit | 55 | 410.71 | 22.6K | 131 | — | ↗ |
| 2022-03-21 | Witherspoon Charles | — | — | D | Common Stock | 0 | 0.00 | — | 1,422 | — | ↗ |
| 2022-03-21 | Reiss-Clark Cindy | — | — | D | Common Stock | 0 | 0.00 | — | 3,350 | — | ↗ |
| 2022-03-14 | Lai Quintin J | Officer | S-Sale | D | Common Stock | 900 | 372.92 | 335.6K | 8,512 | — | ↗ |
| 2022-02-23 | Witherspoon Charles | — | — | D | Stock Options (Right to buy) | 1,192 | 274.29 | 327.0K | 0 | — | ↗ |
| 2022-02-23 | Reiss-Clark Cindy | — | — | D | Stock Options (Right to buy) | 3,176 | 274.29 | 871.1K | 0 | — | ↗ |
| 2022-02-22 | Winters Chad | — | A-Award | A | Common Stock | 414 | 369.13 | 152.8K | 1,073 | — | ↗ |
| 2022-02-22 | MacKay Kimberly Banks | — | A-Award | A | Stock Options (Right to buy) | 3,108 | 369.13 | 1.15M | 3,108 | — | ↗ |
| 2022-02-22 | MONTECALVO DAVID A | — | A-Award | A | Stock Options (Right to buy) | 2,848 | 369.13 | 1.05M | 2,848 | — | ↗ |
| 2022-02-22 | Lai Quintin J | — | A-Award | A | Stock Options (Right to buy) | 1,812 | 369.13 | 668.9K | 1,812 | — | ↗ |
| 2022-02-22 | Green Eric Mark | — | A-Award | A | Stock Options (Right to buy) | 31,088 | 369.13 | 11.48M | 31,088 | — | ↗ |
| 2022-02-22 | Favorite Annette F | — | A-Award | A | Stock Options (Right to buy) | 3,108 | 369.13 | 1.15M | 3,108 | — | ↗ |
| 2022-02-22 | Birkett Bernard | — | A-Award | A | Common Stock | 4,346 | 369.13 | 1.60M | 15,915 | — | ↗ |
| 2022-02-22 | Abraham Silji | — | A-Award | A | Common Stock | 2,498 | 369.13 | 922.1K | 8,575 | — | ↗ |
| 2022-02-13 | MONTECALVO DAVID A | — | F-InKind | D | Common Stock | 27 | 391.20 | 10.6K | 10,134 | — | ↗ |
| 2022-02-13 | Green Eric Mark | — | F-InKind | D | Common Stock | 85 | 391.20 | 33.3K | 86,818 | — | ↗ |
| 2021-12-31 | Joseph Molly | — | A-Award | A | Phantom Stock Unit | 48 | 0.00 | — | 76 | — | ↗ |
| 2021-12-31 | Green Eric Mark | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | BUTHMAN MARK A | — | A-Award | A | Phantom Stock Unit | 48 | 0.00 | — | 10,879 | — | ↗ |
| 2021-12-02 | MacKay Kimberly Banks | — | — | D | Stock Options (Right to buy) | 2,360 | 275.39 | 649.9K | 0 | — | ↗ |
| 2021-10-29 | Winters Chad | — | F-InKind | D | Common Stock | 47 | 429.88 | 20.2K | 659 | — | ↗ |
| 2021-09-30 | Joseph Molly | — | A-Award | A | Phantom Stock Unit | 28 | 0.00 | — | 28 | — | ↗ |
| 2021-09-30 | BUTHMAN MARK A | — | A-Award | A | Phantom Stock Unit | 53 | 0.00 | — | 10,831 | — | ↗ |
| 2021-09-26 | MONTECALVO DAVID A | — | F-InKind | D | Common Stock | 620 | 457.11 | 283.4K | 10,161 | — | ↗ |
| 2021-09-10 | Lai Quintin J | — | S-Sale | D | Common Stock | 1,500 | 462.63 | 693.9K | 2,234 | — | ↗ |
| 2021-09-09 | ZENNER PATRICK J | — | G-Gift | D | Common Stock | 11,517 | 0.00 | — | 55,682 | — | ↗ |
| 2021-08-23 | Joseph Molly | — | — | D | Common Stock | 0 | 0.00 | — | 308 | — | ↗ |
| 2021-06-30 | BUTHMAN MARK A | — | A-Award | A | Phantom Stock Unit | 63 | 0.00 | — | 10,778 | — | ↗ |
| 2021-06-21 | Birkett Bernard | — | F-InKind | D | Common Stock | 1,090 | 357.59 | 389.8K | 11,569 | — | ↗ |
| 2021-05-10 | Abraham Silji | — | S-Sale | D | Common Stock | 2,171 | 335.00 | 727.3K | 6,077 | — | ↗ |
| 2021-05-05 | Winters Chad | — | F-InKind | D | Common Stock | 10 | 328.60 | 3.3K | 706 | — | ↗ |
| 2021-05-04 | ZENNER PATRICK J | — | A-Award | A | Common Stock | 790 | 0.00 | — | 67,509 | — | ↗ |
| 2021-05-04 | Pucci Paolo | — | A-Award | A | Common Stock | 577 | 0.00 | — | 8,064 | — | ↗ |
| 2021-05-04 | Michels Douglas A | — | A-Award | A | Common Stock | 577 | 0.00 | — | 42,288 | — | ↗ |
| 2021-05-04 | LAI GOLDMAN MYLA | — | A-Award | A | Common Stock | 577 | 0.00 | — | 16,541 | — | ↗ |
| 2021-05-04 | Keller Deborah L | — | A-Award | A | Common Stock | 577 | 0.00 | — | 7,774 | — | ↗ |
| 2021-05-04 | Hofmann Thomas W | — | A-Award | A | Common Stock | 577 | 0.00 | — | 43,580 | — | ↗ |
| 2021-05-04 | Feehery William F | — | A-Award | A | Common Stock | 577 | 0.00 | — | 28,480 | — | ↗ |
Executive team
Top executives
EBIT / Employee
56.5K
Shares Outstanding
70.65M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Robert W. McMahon SVP, Chief Financial Officer | 292.3K | 3.12M | 5.84M | 1.47M | 403.4K | 684.9K | 11.80M | 61.92% | ↗ |
| 2 | 2025 | Eric M. Green President and CEO, Chair of Board | 1.18M | — | 3.33M | 1.11M | 1.47M | 106.0K | 7.19M | 61.69% | ↗ |
| 3 | 2025 | Shane A. Campbell SVP, Chief Proprietary Segment Officer | 369.2K | 100.0K | 1.19M | 260.0K | 455.7K | 24.9K | 2.40M | 60.47% | ↗ |
| 4 | 2025 | Bernard J. Birkett Former SVP, Chief Financial Officer | 637.8K | — | 1.10M | 366.9K | — | 37.3K | 2.14M | 68.50% | ↗ |
| 5 | 2025 | Annette F. Favorite SVP, Chief Human Resources Officer | 450.0K | — | 342.9K | 114.2K | 448.6K | 34.3K | 1.39M | 32.88% | ↗ |
| 6 | 2025 | Kimberly B. MacKay Former SVP, General Counsel and Secretary | 487.0K | — | 318.2K | 106.1K | 316.6K | 30.4K | 1.26M | 33.72% | ↗ |
| 7 | 2024 | Eric M. Green President and CEO, Chair of Board | 1.17M | — | 3.40M | 3.40M | 294.7K | 128.5K | 8.39M | 81.01% | ↗ |
| 8 | 2024 | Bernard J. Birkett SVP, Chief Financial Officer | 717.0K | — | 1.13M | 1.13M | 108.3K | 62.1K | 3.14M | 71.72% | ↗ |
| 9 | 2024 | Bernard J. Birkett Former SVP, Chief Financial Officer | 717.0K | — | 1.13M | 1.13M | 108.3K | 62.1K | 3.14M | 71.72% | ↗ |
| 10 | 2024 | Silji Abraham SVP, Chief Technology Officer | 539.2K | — | 400.3K | 400.1K | — | 45.4K | 1.38M | 57.79% | ↗ |
| 11 | 2024 | Annette F. Favorite SVP, Chief Human Resources Officer | 447.4K | — | 350.2K | 350.1K | 58.6K | 42.1K | 1.25M | 56.10% | ↗ |
| 12 | 2024 | Kimberly B. MacKay Former SVP, General Counsel and Secretary | 484.3K | — | 325.3K | 325.0K | 58.5K | 40.9K | 1.23M | 52.70% | ↗ |
| 13 | 2024 | Kimberly B. MacKay SVP, General Counsel and Secretary | 484.3K | — | 325.3K | 325.0K | 58.5K | 40.9K | 1.23M | 52.70% | ↗ |
| 14 | 2023 | Eric M. Green President and CEO, Chair of Board | 1.14M | — | 3.25M | 3.25M | 1.67M | 115.2K | 9.42M | 69.02% | ↗ |
| 15 | 2023 | Eric M. Green President & Chief Executive Officer | 1.14M | — | 3.25M | 3.25M | 1.67M | 92.5K | 9.40M | 69.18% | ↗ |
| 16 | 2023 | Bernard J. Birkett SVP, Chief Financial Officer | 693.3K | — | 1.13M | 1.12M | 637.9K | 55.7K | 3.64M | 61.87% | ↗ |
| 17 | 2023 | Bernard J. Birkett Former SVP, Chief Financial Officer | 693.3K | — | 1.13M | 1.12M | 637.9K | 55.7K | 3.64M | 61.87% | ↗ |
| 18 | 2023 | Bernard J. Birkett SVP, Chief Financial & Operations Officer | 693.3K | — | 1.13M | 1.12M | 637.9K | 55.7K | 3.64M | 61.87% | ↗ |
| 19 | 2023 | Silji Abraham SVP & Chief Technology Officer | 520.2K | — | 350.2K | 349.9K | 414.6K | 37.3K | 1.67M | 41.87% | ↗ |
| 20 | 2023 | Silji Abraham SVP, Chief Technology Officer | 520.2K | — | 350.2K | 349.9K | 414.6K | 37.3K | 1.67M | 41.87% | ↗ |
| 21 | 2023 | Cindy Reiss-Clark SVP & Chief Commercial Officer | 470.2K | — | 325.1K | 325.1K | 375.1K | 34.2K | 1.53M | 42.50% | ↗ |
| 22 | 2023 | Kimberly B. MacKay SVP, General Counsel | 462.3K | — | 325.1K | 325.1K | 344.8K | 34.4K | 1.49M | 43.59% | ↗ |
| 23 | 2023 | Kimberly B. MacKay Former SVP, General Counsel and Secretary | 462.3K | — | 325.1K | 325.1K | 344.8K | 34.4K | 1.49M | 43.59% | ↗ |
| 24 | 2023 | Kimberly B. MacKay SVP, General Counsel and Secretary | 462.3K | — | 325.1K | 325.1K | 344.8K | 34.4K | 1.49M | 43.59% | ↗ |
| 25 | 2022 | Eric M. Green President and CEO, Chair of Board | 1.10M | — | 3.00M | 3.00M | 675.3K | 131.0K | 7.91M | 75.90% | ↗ |
| 26 | 2022 | Eric M. Green President & Chief Executive Officer | 1.10M | — | 3.00M | 3.00M | 675.3K | 131.0K | 7.91M | 75.90% | ↗ |
| 27 | 2022 | Bernard J. Birkett SVP, Chief Financial & Operations Officer | 652.7K | — | 1.08M | 1.07M | 249.9K | 70.2K | 3.12M | 68.85% | ↗ |
| 28 | 2022 | Bernard J. Birkett SVP, Chief Financial Officer | 652.7K | — | 1.08M | 1.07M | 249.9K | 70.2K | 3.12M | 68.85% | ↗ |
| 29 | 2022 | Kimberly B. MacKay SVP General Counsel & Corporate Secretary | 455.0K | — | 300.1K | 299.9K | 138.4K | 256.6K | 1.45M | 41.52% | ↗ |
| 30 | 2022 | Kimberly B. MacKay SVP, General Counsel | 450.2K | — | 300.1K | 299.9K | 138.4K | 256.6K | 1.45M | 41.52% | ↗ |
| 31 | 2022 | Kimberly B. MacKay SVP, General Counsel and Secretary | 450.2K | — | 300.1K | 299.9K | 138.4K | 256.6K | 1.45M | 41.52% | ↗ |
| 32 | 2022 | Silji Abraham SVP, Chief Technology Officer | 495.2K | — | 300.1K | 299.9K | 164.8K | 47.1K | 1.31M | 45.90% | ↗ |
| 33 | 2022 | Silji Abraham SVP & Chief Technology Officer | 495.2K | — | 300.1K | 299.9K | 164.8K | 47.1K | 1.31M | 45.90% | ↗ |
| 34 | 2022 | Cindy Reiss-Clark SVP & Chief Commercial Officer | 438.5K | — | 300.1K | 299.9K | 136.9K | 38.7K | 1.21M | 49.42% | ↗ |
| 35 | 2021 | Eric M. Green President & Chief Executive Officer | 1.04M | — | 3.31M | 2.75M | 2.23M | 144.7K | 9.47M | 63.95% | ↗ |
| 36 | 2021 | Bernard J. Birkett SVP, Chief Financial & Operations Officer | 620.2K | — | 842.2K | 700.1K | 808.1K | 72.7K | 3.04M | 50.68% | ↗ |
| 37 | 2021 | Bernard J. Birkett SVP, CFO & Treasurer Finance | 620.2K | — | 842.2K | 700.1K | 808.1K | 72.7K | 3.04M | 50.68% | ↗ |
| 38 | 2021 | Silji Abraham SVP & Chief Digital & Transf Officer | 469.2K | — | 330.9K | 274.9K | 570.3K | 68.9K | 1.71M | 35.34% | ↗ |
| 39 | 2021 | Silji Abraham SVP & Chief Technology Officer | 469.2K | — | 330.9K | 274.9K | 570.3K | 68.9K | 1.71M | 35.34% | ↗ |
| 40 | 2021 | David A. Montecalvo SVP Global Operations & Supple Chain | 466.2K | — | 330.9K | 274.9K | 564.3K | 48.7K | 1.68M | 35.96% | ↗ |
| 41 | 2021 | Kimberly B. MacKay SVP, General Counsel | 430.0K | — | 330.9K | 274.9K | 476.5K | 39.9K | 1.55M | 39.03% | ↗ |
| 42 | 2021 | Kimberly B. MacKay SVP General Counsel & Corporate Secretary | 430.0K | — | 330.9K | 274.9K | 476.5K | 39.9K | 1.55M | 39.03% | ↗ |
| 43 | 2021 | Kimberly MacKay Sr VP General Counsel & Corporate Secretary | 430.0K | — | 330.9K | 274.9K | 476.5K | 39.9K | 1.55M | 39.03% | ↗ |
| 44 | 2020 | Eric M. Green President & Chief Executive Officer | 989.4K | — | 2.25M | 2.25M | 1.98M | 171.4K | 7.64M | 58.88% | ↗ |
| 45 | 2020 | Bernard J. Birkett SVP, Chief Financial & Operations Officer | 593.7K | — | 500.1K | 500.0K | 792.5K | 72.1K | 2.46M | 40.68% | ↗ |
| 46 | 2020 | Bernard J. Birkett SVP, CFO & Treasurer Finance | 593.7K | — | 500.1K | 500.0K | 792.5K | 72.1K | 2.46M | 40.68% | ↗ |
| 47 | 2020 | Silji Abraham SVP & Chief Technology Officer | 440.8K | — | 400.0K | 400.0K | 545.8K | 42.0K | 1.83M | 43.75% | ↗ |
| 48 | 2020 | Silji Abraham SVP & Chief Digital & Transf Officer | 440.8K | — | 400.0K | 400.0K | 545.8K | 42.0K | 1.83M | 43.75% | ↗ |
| 49 | 2020 | George Miller Sr VP General Counsel & Corporate Secretary | 451.3K | — | 300.0K | 300.0K | 556.9K | 48.2K | 1.66M | 36.23% | ↗ |
| 50 | 2020 | David A. Montecalvo SVP Global Operations & Supple Chain | 445.2K | — | 250.1K | 250.0K | 551.9K | 52.9K | 1.55M | 32.26% | ↗ |
| 51 | 2019 | Eric M. Green President & Chief Executive Officer | 935.8K | — | 2.10M | 2.10M | 1.23M | 169.5K | 6.53M | 64.28% | ↗ |
| 52 | 2019 | Bernard J. Birkett SVP, CFO & Treasurer Finance | 564.4K | 91.7K | 383.3K | 375.0K | 491.4K | 35.2K | 1.94M | 39.07% | ↗ |
| 53 | 2019 | Karen A. Flynn Former SVP & Chief Commercial Officer | 503.5K | — | 350.1K | 350.0K | 437.6K | 148.2K | 1.79M | 39.12% | ↗ |
| 54 | 2019 | George L. Miller Sr VP General Counsel | 438.2K | — | 351.8K | 300.0K | 354.1K | 48.4K | 1.49M | 43.68% | ↗ |
| 55 | 2019 | George Miller Sr VP General Counsel & Corporate Secretary | 438.2K | — | 351.8K | 300.0K | 354.1K | 48.4K | 1.49M | 43.68% | ↗ |
| 56 | 2019 | Silji Abraham SVP & Chief Digital & Transf Officer | 421.0K | — | 240.6K | 200.0K | 340.4K | 35.1K | 1.24M | 35.62% | ↗ |
| 57 | 2019 | Silji Abraham SVP & Chief Digital | 421.0K | — | 240.6K | 200.0K | 340.4K | 35.1K | 1.24M | 35.62% | ↗ |
| 58 | 2019 | David A. Montecalvo SVP Global Operations | 421.9K | — | 211.2K | 200.0K | 342.0K | 48.3K | 1.22M | 33.61% | ↗ |
| 59 | 2019 | David A. Montecalvo SVP Global Operations & Supple Chain | 421.9K | — | 211.2K | 200.0K | 342.0K | 48.3K | 1.22M | 33.61% | ↗ |
| 60 | 2018 | Eric M. Green President & Chief Executive Officer | 879.6K | — | 1.78M | 1.75M | 865.1K | 107.6K | 5.38M | 65.56% | ↗ |
| 61 | 2018 | Bernard J. Birkett SVP, CFO & Treasurer Finance | 279.2K | 390.0K | 1.31M | 312.5K | 190.5K | 319.1K | 2.80M | 57.96% | ↗ |
| 62 | 2018 | William J. Federici Former SVP, CFO | 491.1K | — | 350.0K | 350.0K | 340.0K | 114.2K | 1.65M | 42.55% | ↗ |
| 63 | 2018 | David A. Montecalvo SVP Global Operations | 401.5K | — | 407.1K | 400.0K | 264.3K | 46.7K | 1.52M | 53.12% | ↗ |
| 64 | 2018 | David A. Montecalvo SVP Global Operations & Supple Chain | 401.5K | — | 407.1K | 400.0K | 264.3K | 46.7K | 1.52M | 53.12% | ↗ |
| 65 | 2018 | Karen A. Flynn SVP & Chief Commercial Officer | 492.7K | — | 350.0K | 350.0K | 260.0K | 44.5K | 1.50M | 46.76% | ↗ |
| 66 | 2018 | Karen A. Flynn Former SVP & Chief Commercial Officer | 492.7K | — | 350.0K | 350.0K | 260.0K | 44.5K | 1.50M | 46.76% | ↗ |
| 67 | 2018 | Silji Abraham SVP & Chief Digital & Transf Officer | 339.0K | 68.3K | 600.0K | 200.0K | 241.6K | 42.6K | 1.49M | 53.63% | ↗ |
| 68 | 2018 | Silji Abraham SVP & Chief Digital | 339.0K | 68.3K | 600.0K | 200.0K | 241.6K | 42.6K | 1.49M | 53.63% | ↗ |
| 69 | 2018 | George L. Miller Sr VP General Counsel | 426.0K | — | 351.9K | 300.0K | 256.2K | 72.3K | 1.41M | 46.35% | ↗ |
| 70 | 2018 | George Miller Sr VP General Counsel & Corporate Secretary | 426.0K | — | 351.9K | 300.0K | 256.2K | 72.3K | 1.41M | 46.35% | ↗ |
| 71 | 2017 | Eric M. Green President & Chief Executive Officer | 824.0K | — | 1.53M | 1.50M | 748.8K | 156.8K | 4.76M | 63.64% | ↗ |
| 72 | 2017 | Karen A. Flynn Sr. VP & Chief Commercial Officer | 469.6K | — | 500.1K | 500.0K | 281.9K | 151.1K | 1.90M | 52.56% | ↗ |
| 73 | 2017 | Karen A. Flynn Former SVP & Chief Commercial Officer | 469.6K | — | 500.1K | 500.0K | 281.9K | 151.1K | 1.90M | 52.56% | ↗ |
| 74 | 2017 | Karen A. Flynn SVP & Chief Commercial Officer | 469.6K | — | 500.1K | 500.0K | 281.9K | 151.1K | 1.90M | 52.56% | ↗ |
| 75 | 2017 | William J. Federici Sr. VP, Chief Financial Officer & Treasurer | 535.5K | — | 350.0K | 350.0K | 340.4K | 301.5K | 1.88M | 37.29% | ↗ |
| 76 | 2017 | William J. Federici Former SVP, CFO | 535.5K | — | 350.0K | 350.0K | 340.4K | 301.5K | 1.88M | 37.29% | ↗ |
| 77 | 2017 | George L. Miller Sr. VP, General Counsel & Corporate Secretary | 409.8K | — | 356.5K | 300.0K | 226.3K | 75.0K | 1.37M | 48.00% | ↗ |
| 78 | 2017 | George L. Miller Sr VP General Counsel | 409.8K | — | 356.5K | 300.0K | 226.3K | 75.0K | 1.37M | 48.00% | ↗ |
| 79 | 2017 | David A. Montecalvo Sr. VP, Global Operations & Supply Chain | 377.8K | — | 202.3K | 199.9K | 166.4K | 167.9K | 1.11M | 36.09% | ↗ |
| 80 | 2017 | David A. Montecalvo SVP Global Operations | 377.8K | — | 202.3K | 199.9K | 166.4K | 167.9K | 1.11M | 36.09% | ↗ |
| 81 | 2016 | Eric M. Green President & Chief Executive Officer | 749.0K | — | 1.03M | 1.00M | 738.6K | 134.2K | 3.65M | 55.54% | ↗ |
| 82 | 2016 | William J. Federici Former SVP, CFO | 517.3K | — | 350.0K | 350.0K | 375.2K | 271.1K | 1.86M | 37.56% | ↗ |
| 83 | 2016 | William J. Federici Sr. VP, Chief Financial Officer & Treasurer | 517.3K | — | 350.0K | 350.0K | 375.2K | 271.1K | 1.86M | 37.56% | ↗ |
| 84 | 2016 | William J. Federici Sr. V.P, Chief Financial Officer & Treasurer | 517.3K | — | 350.0K | 350.0K | 375.2K | 271.1K | 1.86M | 37.56% | ↗ |
| 85 | 2016 | Karen A. Flynn SVP & Chief Commercial Officer | 439.9K | — | 350.0K | 350.0K | 310.0K | 118.8K | 1.57M | 44.63% | ↗ |
| 86 | 2016 | Karen A. Flynn Sr. V.P. & Chief Commercial Officer | 439.9K | — | 350.0K | 350.0K | 310.0K | 118.8K | 1.57M | 44.63% | ↗ |
| 87 | 2016 | Karen A. Flynn Sr. VP & Chief Commercial Officer | 439.9K | — | 350.0K | 350.0K | 310.0K | 118.8K | 1.57M | 44.63% | ↗ |
| 88 | 2016 | George L. Miller Sr. V.P., General Counsel & Corporate Secretary | 400.0K | — | 300.0K | 300.0K | 247.8K | 267.4K | 1.52M | 39.60% | ↗ |
| 89 | 2016 | George L. Miller Sr. VP, General Counsel & Corporate Secretary | 400.0K | — | 300.0K | 300.0K | 247.8K | 267.4K | 1.52M | 39.60% | ↗ |
| 90 | 2016 | Annette F. Favorite Sr. V.P. & CHRO | 300.0K | 150.0K | 158.7K | 150.0K | 171.5K | 210.6K | 1.14M | 27.06% | ↗ |
| 91 | 2015 | Eric M. Green President & Chief Executive Officer | 473.8K | 616.7K | 3.17M | 3.18M | 614.3K | 310.6K | 8.37M | 75.91% | ↗ |
| 92 | 2015 | Eric M. Green President and Chief Executive Officer | 473.8K | 616.7K | 3.17M | 3.18M | 614.3K | 310.6K | 8.37M | 75.91% | ↗ |
| 93 | 2015 | Donald E. Morel, Jr. Former Chairman and Chief Executive Officer | 461.9K | — | 1.20M | 1.20M | 537.4K | 1.21M | 4.61M | 52.09% | ↗ |
| 94 | 2015 | William J. Federici Sr. VP, Chief Financial Officer & Treasurer | 515.5K | — | 350.0K | 350.0K | 447.2K | 144.3K | 1.81M | 38.74% | ↗ |
| 95 | 2015 | William J. Federici Sr. V.P. and Chief Financial Officer | 515.5K | — | 350.0K | 350.0K | 447.2K | 144.3K | 1.81M | 38.74% | ↗ |
| 96 | 2015 | William J. Federici Sr. V.P, Chief Financial Officer & Treasurer | 515.5K | — | 350.0K | 350.0K | 447.2K | 144.3K | 1.81M | 38.74% | ↗ |
| 97 | 2015 | Karen A. Flynn Sr. V.P. & Chief Commercial Officer | 425.5K | — | 312.5K | 326.7K | 359.6K | 52.5K | 1.48M | 43.28% | ↗ |
| 98 | 2015 | Karen A. Flynn Sr. V.P. and Chief Commercial Officer | 425.5K | — | 312.5K | 326.7K | 359.6K | 52.5K | 1.48M | 43.28% | ↗ |
| 99 | 2015 | Karen A. Flynn Sr. VP & Chief Commercial Officer | 425.5K | — | 312.5K | 326.7K | 359.6K | 52.5K | 1.48M | 43.28% | ↗ |
| 100 | 2015 | John E. Paproski Sr. V.P. and Chief Technology Officer | 374.2K | — | 300.0K | 300.0K | 272.6K | 143.6K | 1.39M | 43.15% | ↗ |
| 101 | 2015 | George L. Miller Sr. V.P., General Counsel & Corporate Secretary | 41.5K | 66.7K | 700.1K | 300.0K | — | 16.2K | 1.12M | 88.94% | ↗ |
| 102 | 2015 | George L. Miller Sr. VP, General Counsel & Corporate Secretary | 41.5K | 66.7K | 700.1K | 300.0K | — | 16.2K | 1.12M | 88.94% | ↗ |
| 103 | 2015 | George L. Miller Sr. V.P., General Counsel and Corporate Secretary | 41.5K | 66.7K | 700.1K | 300.0K | — | 16.2K | 1.12M | 88.94% | ↗ |
| 104 | 2014 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 837.7K | — | 1.20M | 1.20M | 723.9K | 928.4K | 4.89M | 49.08% | ↗ |
| 105 | 2014 | Donald E. Morel, Jr. Former Chairman and Chief Executive Officer | 837.7K | — | 1.20M | 1.20M | 723.9K | 928.4K | 4.89M | 49.08% | ↗ |
| 106 | 2014 | William J. Federici Sr. V.P. and Chief Financial Officer | 467.0K | — | 350.0K | 350.0K | 282.0K | 281.2K | 1.73M | 40.46% | ↗ |
| 107 | 2014 | William J. Federici Senior Vice President and Chief Financial Officer | 467.0K | — | 350.0K | 350.0K | 282.0K | 281.2K | 1.73M | 40.46% | ↗ |
| 108 | 2014 | William J. Federici Sr. V.P, Chief Financial Officer & Treasurer | 467.0K | — | 350.0K | 350.0K | 282.0K | 281.2K | 1.73M | 40.46% | ↗ |
| 109 | 2014 | John E. Paproski President, Pharmaceutical Delivery Systems | 350.3K | — | 300.0K | 300.0K | 234.2K | 430.0K | 1.61M | 37.16% | ↗ |
| 110 | 2014 | John E. Paproski Sr. V.P. and Chief Technology Officer | 350.3K | — | 300.0K | 300.0K | 234.2K | 430.0K | 1.61M | 37.16% | ↗ |
| 111 | 2014 | Jeffrey C. Hunt Former President, Pharmaceutical Packaging Systems | 247.1K | — | 344.8K | 300.0K | 122.4K | 459.2K | 1.47M | 43.76% | ↗ |
| 112 | 2014 | Karen A. Flynn Sr. V.P. & Chief Commercial Officer | 346.0K | — | 310.0K | 300.0K | 214.8K | 127.6K | 1.30M | 46.98% | ↗ |
| 113 | 2014 | Karen A. Flynn Sr. V.P. and Chief Commercial Officer | 346.0K | — | 310.0K | 300.0K | 214.8K | 127.6K | 1.30M | 46.98% | ↗ |
| 114 | 2014 | Karen A. Flynn President, Pharmaceutical Packaging Systems | 346.0K | — | 310.0K | 300.0K | 214.8K | 127.6K | 1.30M | 46.98% | ↗ |
| 115 | 2014 | Warwick Bedwell President, Pharmaceutical Packaging Systems, Asia Pacific Region | 339.1K | — | 150.0K | 150.0K | 148.9K | 184.4K | 972.3K | 30.86% | ↗ |
| 116 | 2013 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 825.0K | — | 1.20M | 1.20M | 1.07M | 216.0K | 4.51M | 53.17% | ↗ |
| 117 | 2013 | Donald E. Morel, Jr. Former Chairman and Chief Executive Officer | 825.0K | — | 1.20M | 1.20M | 1.07M | 216.0K | 4.51M | 53.17% | ↗ |
| 118 | 2013 | William J. Federici Sr. V.P. and Chief Financial Officer | 457.9K | — | 350.0K | 350.0K | 419.8K | 130.1K | 1.71M | 40.99% | ↗ |
| 119 | 2013 | William J. Federici Senior Vice President and Chief Financial Officer | 457.9K | — | 350.0K | 350.0K | 419.8K | 130.1K | 1.71M | 40.99% | ↗ |
| 120 | 2013 | Jeffrey C. Hunt Former President, Pharmaceutical Packaging Systems | 394.8K | — | 368.2K | 300.0K | 365.9K | 86.2K | 1.52M | 44.10% | ↗ |
| 121 | 2013 | Jeffrey C. Hunt President, Pharmaceutical Packaging Systems | 394.8K | — | 368.2K | 300.0K | 365.9K | 86.2K | 1.52M | 44.10% | ↗ |
| 122 | 2013 | John E. Paproski President, Pharmaceutical Delivery Systems | 339.9K | — | 300.0K | 300.0K | 286.3K | 100.9K | 1.33M | 45.21% | ↗ |
| 123 | 2013 | John E. Paproski Sr. V.P. and Chief Technology Officer | 339.9K | — | 300.0K | 300.0K | 286.3K | 100.9K | 1.33M | 45.21% | ↗ |
| 124 | 2013 | Warwick Bedwell President, Pharmaceutical Packaging Systems, Asia Pacific Region | 359.3K | — | 162.8K | 150.0K | 239.5K | 189.8K | 1.10M | 28.40% | ↗ |
| 125 | 2012 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 825.0K | — | 1.00M | 1,000.0K | 1.21M | 849.6K | 4.89M | 40.94% | ↗ |
| 126 | 2012 | William J. Federici Vice President and Chief Financial Officer | 448.5K | — | 325.0K | 325.0K | 464.8K | 255.1K | 1.82M | 35.75% | ↗ |
| 127 | 2012 | William J. Federici Senior Vice President and Chief Financial Officer | 448.5K | — | 325.0K | 325.0K | 464.8K | 255.1K | 1.82M | 35.75% | ↗ |
| 128 | 2012 | John E. Paproski President, Pharmaceutical Delivery Systems | 321.3K | — | 250.0K | 250.0K | 306.3K | 307.9K | 1.44M | 34.83% | ↗ |
| 129 | 2012 | Jeffrey C. Hunt President, Pharmaceutical Packaging Systems | 384.8K | — | 260.0K | 250.0K | 381.5K | 67.8K | 1.34M | 37.94% | ↗ |
| 130 | 2012 | Jeffrey C. Hunt Former President, Pharmaceutical Packaging Systems | 384.8K | — | 260.0K | 250.0K | 381.5K | 67.8K | 1.34M | 37.94% | ↗ |
| 131 | 2012 | Warwick Bedwell President, Pharmaceutical Packaging Systems, Asia Pacific Region | 349.6K | — | 150.0K | 150.0K | 301.5K | 187.3K | 1.14M | 26.35% | ↗ |
| 132 | 2011 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 825.0K | — | 1.10M | 1.10M | 736.4K | 785.8K | 4.55M | 48.38% | ↗ |
| 133 | 2011 | William J. Federici Vice President and Chief Financial Officer | 441.3K | — | 300.0K | 300.0K | 275.7K | 198.5K | 1.52M | 39.59% | ↗ |
| 134 | 2011 | William J. Federici Senior Vice President and Chief Financial Officer | 441.3K | — | 300.0K | 300.0K | 275.7K | 198.5K | 1.52M | 39.59% | ↗ |
| 135 | 2011 | Jeffrey C. Hunt President, Pharmaceutical Packaging Systems | 371.2K | — | 205.1K | 200.0K | 234.3K | 62.2K | 1.07M | 37.76% | ↗ |
| 136 | 2011 | Warwick Bedwell President, Pharmaceutical Packaging Systems, Asia Pacific Region | 347.0K | — | 150.0K | 150.0K | 201.6K | 211.7K | 1.06M | 28.29% | ↗ |
| 137 | 2011 | Heino Lennartz President, Pharmaceutical Packaging Systems, Europe Region | 314.9K | 856.00 | 150.0K | 150.0K | 186.6K | 43.8K | 846.2K | 35.45% | ↗ |
| 138 | 2010 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 825.0K | — | 1.26M | 1.46M | 890.1K | 516.3K | 4.95M | 54.88% | ↗ |
| 139 | 2010 | Steven A. Ellers President and Chief Operating Officer | 512.8K | — | 514.1K | 496.4K | 435.1K | 400.8K | 2.36M | 42.83% | ↗ |
| 140 | 2010 | William J. Federici Vice President and Chief Financial Officer | 436.8K | — | 342.7K | 397.6K | 320.2K | 186.7K | 1.68M | 43.96% | ↗ |
| 141 | 2010 | John R, Gailey III Vice President, General Counsel, Secretary and Compliance Officer | 329.3K | — | 171.4K | 198.8K | 171.1K | 176.4K | 1.05M | 35.36% | ↗ |
| 142 | 2010 | Ron van Dijk President Pharmaceutical Packaging Systems, Asia-Pacific Region | 279.0K | — | 171.4K | 198.8K | 169.7K | 122.5K | 941.4K | 39.32% | ↗ |
| 143 | 2010 | Heino Lennartz President, Pharmaceutical Packaging Systems, Europe Region | 293.5K | 817.00 | 171.4K | 198.8K | 183.8K | 56.0K | 904.4K | 40.93% | ↗ |
| 144 | 2010 | Heino Lennartz President Pharmaceutical Packaging Systems, Europe Region | 293.5K | 817.00 | 171.4K | 198.8K | 183.8K | 56.0K | 904.4K | 40.93% | ↗ |
| 145 | 2009 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 809.2K | — | 994.8K | 695.0K | 766.0K | 463.9K | 3.73M | 45.32% | ↗ |
| 146 | 2009 | Steven A. Ellers President and Chief Operating Officer | 493.2K | — | 427.1K | 278.0K | 346.5K | 367.8K | 1.91M | 36.86% | ↗ |
| 147 | 2009 | Matthew T. Mullarkey Former Chief Operating Officer | 394.6K | 35.4K | 401.1K | 147.2K | 281.4K | 181.7K | 1.44M | 38.04% | ↗ |
| 148 | 2009 | William J. Federici Vice President and Chief Financial Officer | 420.2K | — | 256.7K | 180.7K | 253.5K | 163.5K | 1.27M | 34.32% | ↗ |
| 149 | 2009 | John R. Gailey III Vice President, General Counsel and Secretary | 316.7K | — | 128.4K | 90.4K | 145.3K | 176.1K | 856.8K | 25.53% | ↗ |
| 150 | 2009 | John R, Gailey III Vice President, General Counsel, Secretary and Compliance Officer | 316.7K | — | 128.4K | 90.4K | 145.3K | 176.1K | 856.8K | 25.53% | ↗ |
| 151 | 2009 | Heino Lennartz President, Pharmaceutical Packaging Systems, Europe Region | 248.0K | 857.00 | 123.4K | 91.3K | 142.6K | 46.8K | 652.9K | 32.88% | ↗ |
| 152 | 2009 | Heino Lennartz President Pharmaceutical Packaging Systems, Europe Region | 248.0K | 857.00 | 123.4K | 91.3K | 142.6K | 46.8K | 652.9K | 32.88% | ↗ |
| 153 | 2008 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 811.2K | — | 1.52M | 979.0K | 653.4K | 319.2K | 4.28M | 58.35% | ↗ |
| 154 | 2008 | Steven A. Ellers President and Chief Operating Officer | 492.8K | — | 657.6K | 400.5K | 298.7K | 212.1K | 2.06M | 51.32% | ↗ |
| 155 | 2008 | William J. Federici Vice President and Chief Financial Officer | 425.8K | — | 445.1K | 267.0K | 220.5K | 162.4K | 1.52M | 46.82% | ↗ |
| 156 | 2008 | Robert J. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 396.1K | — | 66.4K | 106.0K | 193.4K | 319.9K | 1.08M | 15.94% | ↗ |
| 157 | 2008 | John R. Gailey III Vice President, General Counsel and Secretary | 320.5K | — | 208.3K | 133.5K | 127.9K | 123.0K | 913.2K | 37.43% | ↗ |
| 158 | 2008 | John R, Gailey III Vice President, General Counsel, Secretary and Compliance Officer | 320.5K | — | 208.3K | 133.5K | 127.9K | 123.0K | 913.2K | 37.43% | ↗ |
| 159 | 2007 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 778.4K | — | 1.27M | 1.49M | 676.0K | 292.3K | 4.51M | 61.27% | ↗ |
| 160 | 2007 | Steven A. Ellers President and Chief Operating Officer | 446.8K | — | 549.3K | 609.8K | 288.5K | 169.4K | 2.06M | 56.16% | ↗ |
| 161 | 2007 | William J. Federici Vice President and Chief Financial Officer | 407.7K | — | 355.4K | 406.5K | 236.6K | 135.9K | 1.54M | 49.41% | ↗ |
| 162 | 2007 | Robert J. Keating President, Europe and Asia Pacific | 360.9K | — | 177.3K | 97.6K | 221.6K | 292.1K | 1.15M | 23.91% | ↗ |
| 163 | 2007 | Robert J. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 360.9K | — | 177.3K | 97.6K | 221.6K | 292.1K | 1.15M | 23.91% | ↗ |
| 164 | 2007 | John R. Gailey III Vice President, General Counsel and Secretary | 305.7K | — | 168.9K | 203.3K | 136.5K | 103.7K | 918.0K | 40.54% | ↗ |
| 165 | 2006 | Donald E. Morel, Jr. Chairman of the Board and Chief Executive Officer | 664.1K | 200.00 | 1.16M | 574.9K | 915.9K | 406.3K | 3.72M | 46.62% | ↗ |
| 166 | 2006 | Steven A. Ellers President and Chief Operating Officer | 388.1K | 200.00 | 492.5K | 212.8K | 340.5K | 377.7K | 1.81M | 38.93% | ↗ |
| 167 | 2006 | William J. Federici Vice President and Chief Financial Officer | 376.2K | 100.00 | 246.7K | 106.5K | 280.8K | 111.6K | 1.12M | 31.48% | ↗ |
| 168 | 2006 | Robert J. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 311.9K | — | 147.3K | 65.9K | 224.9K | 279.2K | 1.03M | 20.72% | ↗ |
| 169 | 2006 | Robert J. Keating President, Europe and Asia Pacific | 311.9K | — | 147.3K | 65.9K | 224.9K | 279.2K | 1.03M | 20.72% | ↗ |
| 170 | 2006 | John R. Gailey III Vice President, General Counsel and Secretary | 273.6K | 200.00 | 133.8K | 59.2K | 168.4K | 136.2K | 771.3K | 25.02% | ↗ |
| 171 | 2005 | Dr. Morel Chairman of the Board and Chief Executive Officer | 592.5K | 489.9K | 30.3K | 95.2K | — | 55.0K | 1.26M | 9.94% | ↗ |
| 172 | 2005 | Mr. Ellers President and Chief Operating Officer | 345.8K | 289.5K | 35.9K | 40.0K | — | 40.3K | 751.4K | 10.10% | ↗ |
| 173 | 2005 | Mr. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 284.9K | 197.1K | 6.1K | 13.0K | — | 247.0K | 748.1K | 2.55% | ↗ |
| 174 | 2005 | Mr. Federici Vice President and Chief Financial Officer | 364.5K | 192.3K | 11.9K | 18.0K | — | 30.1K | 616.7K | 4.85% | ↗ |
| 175 | 2005 | Ms. Altemus Vice President and Chief Compliance Officer | 262.4K | 110.3K | 6.8K | 11.0K | — | 24.8K | 415.3K | 4.30% | ↗ |
| 176 | 2004 | Donald E. Morel, Jr., Ph.D Chairman of the Board, Chief Executive Officer and President | 535.8K | 369.6K | 2.76M | 136.0K | — | 27.2K | 3.83M | 75.66% | ↗ |
| 177 | 2004 | Steven A. Ellers President, Pharmaceutical Systems Division | 319.9K | 195.2K | 1.10M | 53.4K | — | 21.0K | 1.69M | 68.30% | ↗ |
| 178 | 2004 | Robert J. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 319.1K | 172.0K | 341.9K | 17.0K | — | 278.5K | 1.13M | 31.81% | ↗ |
| 179 | 2004 | William J. Federici Vice President and Chief Financial Officer | 368.1K | 187.5K | 496.8K | 24.6K | — | 49.7K | 1.13M | 46.27% | ↗ |
| 180 | 2004 | Dr. Morel Chairman of the Board and Chief Executive Officer | 535.8K | 369.6K | 23.4K | 136.0K | — | 51.8K | 1.12M | 14.27% | ↗ |
| 181 | 2004 | Mr. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 319.1K | 172.0K | 5.8K | 17.0K | — | 292.4K | 806.3K | 2.82% | ↗ |
| 182 | 2004 | Herbert L. Hugill President of the Americas, Pharmaceutical Systems Division | 246.7K | 118.4K | 347.3K | 17.0K | — | 17.5K | 746.9K | 48.78% | ↗ |
| 183 | 2004 | Mr. Federici Vice President and Chief Financial Officer | 368.1K | 187.5K | 23.7K | 24.6K | — | 70.1K | 674.1K | 7.16% | ↗ |
| 184 | 2004 | Mr. Ellers President and Chief Operating Officer | 319.9K | 195.2K | 24.7K | 53.4K | — | 34.5K | 627.7K | 12.44% | ↗ |
| 185 | 2004 | Ms. Altemus Vice President and Chief Compliance Officer | 264.5K | 97.0K | 6.2K | 14.6K | — | 24.2K | 406.6K | 5.10% | ↗ |
| 186 | 2003 | Dr. Morel Chairman of the Board and Chief Executive Officer | 482.9K | 545.5K | 11.3K | 120.0K | — | 33.5K | 1.19M | 11.00% | ↗ |
| 187 | 2003 | Donald E. Morel, Jr., Ph.D Chairman of the Board, Chief Executive Officer and President | 482.9K | 545.5K | — | 120.0K | — | 14.5K | 1.16M | 10.32% | ↗ |
| 188 | 2003 | Mr. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 279.6K | 214.1K | 3.2K | 50.0K | — | 278.7K | 825.5K | 6.44% | ↗ |
| 189 | 2003 | Robert J. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 279.6K | 214.1K | — | 50.0K | — | 239.7K | 783.3K | 6.38% | ↗ |
| 190 | 2003 | Mr. Ellers President and Chief Operating Officer | 296.4K | 229.5K | 13.7K | 80.0K | — | 20.3K | 640.0K | 14.64% | ↗ |
| 191 | 2003 | Steven A. Ellers President, Pharmaceutical Systems Division | 296.4K | 229.5K | — | 80.0K | — | 8.9K | 614.8K | 13.01% | ↗ |
| 192 | 2003 | Herbert L. Hugill President of the Americas, Pharmaceutical Systems Division | 228.7K | 157.4K | — | 50.0K | — | 6.9K | 443.0K | 11.29% | ↗ |
| 193 | 2003 | Ms. Altemus Vice President and Chief Compliance Officer | 245.7K | 129.9K | 3.4K | 15.0K | — | 16.2K | 410.1K | 4.48% | ↗ |
| 194 | 2003 | Mr. Federici Vice President and Chief Financial Officer | 121.2K | 171.3K | 3.9K | 100.0K | — | 4.5K | 400.9K | 25.92% | ↗ |
| 195 | 2003 | William J. Federici Vice President and Chief Financial Officer | 121.2K | 171.3K | — | 100.0K | — | 2.8K | 395.3K | 25.30% | ↗ |
| 196 | 2002 | Donald E. Morel, Jr., Ph.D Chairman of the Board, Chief Executive Officer and President | 398.3K | 151.9K | 6.4K | 320.0K | — | 11.9K | 888.5K | 36.74% | ↗ |
| 197 | 2002 | Robert J. Keating President, Europe and Asia Pacific, Pharmaceutical Systems Division | 205.3K | 57.6K | 1.8K | 16.0K | — | 223.7K | 504.4K | 3.52% | ↗ |
| 198 | 2002 | Steven A. Ellers President, Pharmaceutical Systems Division | 280.0K | 92.6K | 3.8K | — | — | 8.4K | 384.9K | 0.99% | ↗ |
| 199 | 2002 | Herbert L. Hugill President of the Americas, Pharmaceutical Systems Division | 216.6K | 61.6K | 2.4K | — | — | 6.5K | 287.1K | 0.85% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert W. McMahon | Senior Vice President & Chief Financial Officer | 4M | male |
| Eric Green | Non-Independent Chair of the Board, President & Chief Executive Officer | 3M | male |
| Devesh Mathur | Senior Vice President & Chief Technology Officer | 972.1K | — |
| Shane Campbell | SVP & Chief Proprietary Segment Officer | 949.8K | male |
| Annette F. Favorite | Chief Human Resources Officer & Senior Vice President | 927.8K | female |
| Kathy DePadua | Senior Vice President and Chief Quality & Regulatory Officer | — | female |
| Michele Polinsky | Vice President of Global Communications | — | female |
| Norman Finch | Senior VP, General Counsel & Corporate Secretary | — | male |
| John Sweeney | Vice President of Investor Relations | — | male |
| Rudy Poussot | Senior Vice President of Strategy & Corporate Development | — | male |
| Chad R. Winters | Vice President of Finance & Chief Accounting Officer | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-07-22 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-06-17 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-04-08 | 2025-05-08 | Rob Bresnahan | PA08 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-02-13 | 2025-03-06 | Jared Moskowitz | FL23 | Dependent | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2024-11-08 | 2024-12-09 | Jared Moskowitz | FL23 | — | Sale | $1,001 - $15,000 | ↗ |
| 2024-09-09 | 2024-10-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2024-09-09 | 2024-10-08 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2024-03-20 | 2024-04-05 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2024-02-13 | 2024-03-06 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-12-28 | 2024-08-21 | Jared Moskowitz | FL23 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-11-03 | 2023-12-06 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-26 | 2023-11-08 | Ro Khanna | CA17 | — | Sale | $15,001 - $50,000 | ↗ |
| 2023-07-14 | 2024-08-21 | Jared Moskowitz | FL23 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-05-23 | 2023-06-12 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-05-23 | 2023-06-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-03-14 | 2023-04-07 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-01-09 | 2023-02-07 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2022-11-03 | 2022-12-06 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2022-10-20 | 2022-11-10 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-06-17 | 2022-07-07 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
